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ABSTRACT 
BACTERIOPHAGE-BASED COLORIMETRIC DETECTION OF ESCHERICHIA 
COLI IN DRINKING WATER 
 
SEPTEMBER 2016 
 
JUHONG CHEN,  
 
B.S., EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Sam R. Nugen and Vincent M. Rotello 
 
 
One of the major safety causes in drinking water is from the bacteria 
contamination, especially in developing countries and resource-limited settings. Although 
many of these Escherichia coli (E. coli) strains in drinking water are nonpathogenic, they 
sever as the indicator for bacterial contamination. And, the more widely used method to 
detect E. coli in drinking water is to determine the activity of β-galactosidase (β-gal), 
which is released by E. coli. Rapid, sensitive and inexpensive detection of E. coli in 
drinking water can reduce the risk of food-borne bacteria infection and stop the disease 
widely spreading.  
In this degree research, phage-based colorimetric methods were developed to 
detect viable Escherichia coli (E. coli) concentration in drinking water. During the phage 
infection cycle, phages can specifically recognize target E. coli cells and release 
intracellular β-gal enzyme. Using our proposed novel biosensor strategies, the β-gal 
enzymatic activity as the indictor for the presence of E. coli in drinking water was 
 vii 
measured. Firstly, T7 phage covalently conjugated to magnetic beads were used to 
capture, separate, and purity E. coli cells from drinking water. The released β-gal was 
determined using commercial colorimetric substrates. Due to the specific chemical and 
physical properties of nanomaterials, T7 phage were immobilized on magnetic 
nanoparticle to improve the capture efficiency of bacteria separation. Next, a novel 
enzyme-induced metallization multi-colorimetric assay was developed to monitor and 
measure β-gal activity, which was further employed for high-resolution colorimetric 
phage-enabled detection of E. coli. In order to improve the limit of detection and decrease 
the effect of the β-gal vary of in different E. coli strains, engineered phage (T7lacZ) 
carrying lacZ gene was furthermore built to force overexpression of β-gal in E. coli cells 
during phage infection. The uses of T7lacZ phage have been demonstrated to become a 
rapid, sensitive, and reliable colorimetric detection of viable E. coli. 
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 1 
CHAPTER 1 
 
INTRODUCTION 
 
Contamination by pathogenic bacteria is a major concern for human health and 
wellness. Rapid detection of pathogenic bacteria enables the reduction of food- and 
water-borne outbreaks in industrial settings, clinical and hospital diagnostics, and water 
and environmental quality controls as well as in resource-limited settings.1-2 Most of 
importance, the bacterial contamination of foods accounts for approximately one-third of 
global deaths and results in approximately 47.8 million illnesses in United State each year, 
in addition to costly recalls.3 The majority bacterial illnesses are a result of an infection or 
intoxication from Staphylococcus aureus (S. aureus), Salmonella typhimurium (S. 
typhimurium), Escherichia coli (E. coli) O157:H7, Listeria monocytogenes, Tuberculosis, 
Streptococcal, Clostridium perfringens, and Bacillus cereus. Although the use of 
antibiotics can treat most bacterial infections, several pathogenic bacteria have become 
resistant to one or more antibiotics, leading to a serious problem. According to World 
Health Organization, current antibiotics will lose effectiveness to control pathogens over 
the next 1-2 decades.4 The presence of multidrug resistant (MDR) pathogens will require 
the development of new therapies which are effective at killing “super bugs”. In the food 
and hospital processing environment, the formation of bacterial biofilms on the surface of 
production equipment can increase fouling, promote corrosion, and contaminate product, 
leading to increased costs and risk.5 Thus, there is an urgent need to develop accurate and 
early-stage screening methods to help reduce the risk of these emerging threats in food, 
medial, and environmental settings. 
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Common methods to detect and quantify bacteria include traditional plate 
counting and polymerase chain reaction (PCR). Plate counting allows an estimation of 
the number of viable bacteria in sample, while PCR enables the detection specific DNA 
or RNA originating from target bacterial cells. Although these methods can be sensitive 
and specific, they require significant sample preparation, potentially increasing total 
assay time beyond 18 hours. There is an on-going challenge in the food and medical 
fields to reduce the time required for results in order to improve mitigation 
responsiveness. Thus, a compelling and urgent need exists to improve the current 
methods for the rapid detection of bacteria. Fortunately, biosensor-based detection 
strategies are a promising tool to meet the aforementioned criteria. The key components 
of a biosensor include a recognition element which binds to target analytes, and a 
transducer which translates the binding event to a measurable signal.6 The performance 
of biosensors is determined by response time, dynamic range, limit of detection (LOD), 
single-to-noise ratio, and specificity.6 Currently, widespread implementation of 
biosensors in the real samples is limited by these factors. Nanomaterials have been 
researched to enhance the performance of biosensors, owing to their unique 
physicochemical properties. Nanomaterials functionalized with recognition elements 
have the ability to create advanced recognition and transduction process, which can 
improve biosensor performance. Specifically, the large surface area of nanomaterials can 
allow a more efficient capture of analytes during biosensing events. Thus, recognition 
element-conjugated nanoscale probes can provide an advanced platform for the detection 
and sensing of pathogenic bacterial cells. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Introduction 
The Centers for Disease Control and Prevention (CDC) estimates bacterial 
pathogens cause 48 million cases of infection, 128000 cases of hospitalization, and 3000 
cases of deaths every year. The conventional method to detect bacteria relies on the 
colony counting method and polymerase chain reaction (PCR).  The colony counting is to 
estimate the number of viable bacteria in sample, and PCR is based on detecting DNA or 
RNA originating from target bacterial cells. The conventional methods used to detect and 
identify pathogenic bacteria are time-consuming and take at least 18 hours from sample 
to results. Although their high sensitivity and specificity of conventional methods, there 
is still compelling and urgent need to develop rapid detection methods.  
This review will cover the interaction between recognition elements and 
nanomaterials in biosensors for bacterial detection. The detection and sensing strategies 
for bacterial cells using nanomaterial-based nanoprobes will be illustrated and discussed. 
During the sensing events, the appropriate choice of recognition element is a key issue in 
development of more effective sensors for bacteria. We will highlight the main 
biosensing recognition elements, including antibodies, aptamers, bacteriophages 
(phages), and selective ligands. Additionally, this review will suggest future directions to 
build recognition element-conjugated nanoprobes in order to improve detection and 
sensing of bacterial cells. 
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2.2 Fabrication of Nanoscale Probes 
Advances in nanotechnology have allowed new nanomaterial-enabled detection 
strategies for the rapid and sensitive detection of pathogenic bacteria. In order to take 
advantage of the unique properties of nanomaterials and fabricate bacteria-selective 
components, recognition elements are modified on the surface of nanomaterials, 
including gold nanoparticles (AuNPs), gold nanorods (AuNRs), magnetic nanoparticles 
(MNPs), graphene oxide (GO), quantum dots (QDs), and upconversion nanoparticles 
(UCNPs). These nanomaterials are functionalized with recognition elements, such as 
antibodies, aptamers, phages, and selective ligands, to specifically recognize and bind to 
epitopes on the surface of bacterial cells (Figure 2.1).  
 
Figure 2.1 Schematic representation showing the fabrication of recognition elements on 
nanomterials as bacteria-selective nanoprobes to detect and sense bacteria cells. 
 
 The immobilization of recognition elements on nanomaterials is an important 
step in the design of nanoscale probes to enhance biosensor performance. Several 
methods have been reported to conjugate biological recognition elements on the surface 
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of nanomaterials, including physical adsorption, covalent bonds, and biotin-streptavidin 
binding.7 Physical adsorption is a non-specific interaction between the recognition 
elements and nanomaterial via hydrogen bonds, hydrophobic interactions, and van der 
Waals forces. Although this method is facile, the random orientation of the biomolecules 
can result in low target capture efficiency, and possible instability can trigger the release 
of target bacterial cells when the local environment is altered (e.g. variance in pH, salt 
concentration, and/or temperature). To circumvent these issues, a covalent bond is 
considered an ideal method to immobilize recognition elements on nanomaterials. The 
amide bond is most commonly used as an intermediate linker to create covalent bonding 
between the amine groups on the recognition elements and the carboxylic acid groups on 
the nanomaterials. Since biotin-conjugated antibodies, aptamers, and engineered phages 
are available, the biotin-streptavidin system has become more popular due to their high 
binding capacity.   
2.3 Antibody-Based Detection of Bacteria Cell 
Antibodies (IgG) are large Y-shape proteins and are produced in immune system 
to identify and detect analytes such as bacterial cells. Antibodies are some of the most 
commonly used biorecognition elements to capture bacterial cells due to their versatility 
and ease of integration into biosensing events. The three categories of IgG antibodies are 
employed in immunology-based assays, including polyclonal, monoclonal, and 
engineered antibody fragments.  
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2.3.1 Plasmonic Noble Metal Nanoprobes 
Synthesis of gold nanomaterials with varying sizes and shapes (e.g. gold nanospheres, 
gold nanorods, gold nanowires, and gold nanostars) has been well defined in the previous 
literature.6 Differing structures and morphologies result in tunable optical properties in 
the visible to near-infrared region, providing optical signals for bacterial cell detection. 
The signals can be observed by monitoring the change of localized surface plasmon 
resonance (LSPR) within the gold nanomaterials. Although silver nanomaterials also 
have surface plasmon resonance, the instability in the air and potential toxicity to bacteria 
can limit their utilization for the detection of bacterial cells.  
2.3.1.1 LSPR for Bacteria Cell Detection 
Due to the unique properties of LSPR, noble nanoparticles modified with 
antibodies have been widely used to develop bacteria biosensors. The refractive index 
change of antibody-conjugated gold nanomaterials causes a shift in the absorbance 
spectral peaks, thus indicating the presence of target bacterial cells. Also, a plasmon peak 
shift caused by LSPR can be used to determine the presence of Salmonella cells as a 
result of the binding between the epitopes of target bacterial cells and antibody-
conjugated AuNPs.8 However, the poor detection limits of antibody-conjugated AuNPs 
limit their practice for bacteria detection. AuNRs have been suggested as a replacement 
for similar sized AuNPs due to their inherently higher sensitivity to a local dielectric 
environment.9  
Wang et al. developed a sensor using antibody-conjugated AuNRs to detect E. 
coli cells. As shown in Figure 2.2a, AuNR nanoprobes were fabricated by functionalizing 
AuNRs with anti-E. coli antibodies, which served as the recognition elements to capture 
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target bacterial cells. The transmission electron microscopy (TEM) micrographs in Figure 
2.2b also allowed visualization of the binding between the nanoprobes and target 
bacterial cells. The specific binding between the AuNR nanoprobes and bacterial cells 
resulted in a redshift. With an increase of target E. coli cell concentration, a larger 
redshift and lower intensity of longitudinal peak bands were observed (Figure 2.2c). The 
results indicated that a limit of detection as low as 102 CFU·mL-1 was achieved in less 
than 30 minutes. Furthermore, multiple pathogenic bacterial strains can be detected using 
different types of antibody-functionalized AuNR nanoprobes. For example, anti-E. coli 
and anti-S. typhimurium antibodies-functionalized onto AuNRs with different aspect 
ratios can simultaneously detect E. coli and S. typhimurium cells at the concentration of 
104 CFU·mL-1.9 AuNRs bifunctionalized with magnetic nanoparticles and antibodies 
were also developed to detect target bacterial cells based on plasmonic resonance. Here, 
the magnetic properties of the binanoprobes were used to separate, purify, and 
concentrate the target bacterial cells.10  
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Figure 2.2 (a) Schematic representation of the synthesis of anti-E. coli antibodies-
conjugated AuNRs nanoprobes. (b) TEM images of the specific interaction of anti-E. coli 
antibodies-conjugated AuNRs with E. coli bacteria cells with different coverage. (c) UV-
vis absorbance spectra of anti-E. coli antibodies-conjugated AuNRs with various 
concentrations of  E. coli bacteria cells (from 10 to 106 CFU·mL-1). 
 
2.2.1.2 Size Depended Colorimetric Detection 
Although the LSPR technique is relatively simple, the requirements of skilled 
operators and sophisticated instruments result in challenges to scale-up for commercial 
applications in low-resource settings. Fortunately, colorimetric assays can help overcome 
these issues by developing portable, easy-to-use, and user-friendly devices for in-situ 
analysis. The aggregation and disaggregation of plasmonic nanomaterials with 
appropriate sizes has been reported for the analysis of metal ions, anions, small organic 
molecules, proteins, and oligonucleotides.6 As a result of being triggered by inter-particle 
crosslinking or being destabilized aggregation of plasmonic gold nanomaterials in the 
presence of target analytes, the color of the detection solution changes from red to blue or 
the reserves at the nanomolar concentration of target analytes, respectively. This color 
change can be visually observed by the naked eye. The principle behind this system is 
that gold nanomaterials modified with antibodies reduce the distance between the 
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individual gold nanomaterials, resulting in inter-particle plasmon coupling and color 
change. The antibodies on the gold nanomaterials can specifically recognize and bind to 
the target whole bacterial cells through antibody-antigen interactions.  
Singh et al. reported anti-E. coli antibody-conjugated AuNRs to selectively detect 
E. coli O157:H7 in an aqueous solution at a concentration as low as 50 CFU·mL-1.11 
Their results indicated the intensity of two-photon Rayleigh scattering of antibody-
conjugated AuNRs increased 40 times in the presence of various competing E. coli cell 
concentrations. The schematic in Figure 2.3a shows the mechanism for the detection of E. 
coli cells using anti-E. coli antibody-conjugated AuNR nanoprobes. Although the size of 
bacterial cells (1-3 µm) is much larger than that of AuNRs, numerous of antibody-
conjugated AuNRs can attach to one bacterial cell, resulting in the aggregation of 
AuNRs. Depending on the concentration of bacterial cells, the degree of aggregation can 
result in different color shifts, ranging from dark green to blue (Figure 2.3b). The 
aggregation of antibody-conjugated AuNRs on the surface of bacterial cells was imaged 
using TEM (Figure 3c). The two-photon scattering intensity change of the detection 
solutions against various concentrations of target bacterial cells are shown in Figure 3d. 
The intensity of the new band appearing around 950 nm was used to indicate the 
aggregation of AuNRs after the addition of target bacterial cells (Figure 3d). In their 
report, the specificity of antibody-conjugated plasmonic nanoprobes was demonstrated 
against competing bacterial cells, including E. coli O157:non-H7 and E. coli O157:NM. 
Similarly, antibody-conjugated oval-shaped gold nanoparticles have been utilized for 
colorimetric detection of S. typhimurium based on the aggregation of plasmonic 
 10 
nanoprobes. As target bacterial cell concentrations increase, the color of the detection 
solutions changes from pink to blue.12  
 
Figure 2.3 (a) Schematic representation of colorimetric detection of E. coli bacteria cells 
using anti-E. coli antibody-conjugated gold nanorods. (b) Photograph of colorimetric 
change after adding E. coli bacteria cells. (c) TEM images of aggregation of anti-E. coli 
antibody-conjugated AuNRs on the surface of E. coli bacteria cells with various 
concentrations (i. control; ii. 102; iii. 8 x 104; and iv. 107 CFU·mL-1) (d) Plot of two 
photon scattering intensity change against bacteria concentrations. 
 
2.3.2 Magnetic Nanoprobes 
Immunomagnetic separation (IMS) consists of antibody-conjugated magnetic 
beads (1-3 micron in diameter) as a powerful tool to separate, concentrate, and purify 
target bacterial cells from complex matrices. The flexibility of this method allows it to be 
combined with numerous detection methods, including fluorescence, colorimetric, 
electrochemical, chemiluminescent, surface-enhanced Raman scattering (SERS), surface 
plasmon resonance (SPR), and quartz crystal microbalance (QCM). Although IMS is 
widely used, low capture efficiencies limit its application in complex matrices. To 
increase capture efficiency, superparamagnetic magnetic nanoparticles (e.g. Fe3O4 and 
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Fe2O3,) have been reported to increase capture efficiency for pathogenic bacteria 
separation from food samples because of their increased surface to volume ratio. 13  
When detecting in complex samples, magnetic separation without centrifugation 
can increase detection sensitivity by purifying target bacterial cells to reduce the 
interference from other compounds. It is well known that MNPs modified with antibodies 
can recognize and attach to the antigens on the surface of bacterial cells. As shown in 
Figure 2.4, the bound bacterial cells can be separated from sample solutions using an 
external magnetic field. The capture efficiency, calculated using the equation shown in 
Figure 2.4, was introduced to measure the performance of antibody-conjugated magnetic 
nanoprobes.14  
The most commonly used magnetic nanoparticle for bacteria separation is iron 
oxide (Fe3O4) MNPs. These nanoparticles have been reported to provide a capture 
efficiency of greater than 90% in real food samples.15 Unfortunately, the MNPs, having a 
diameter of 90 nm, required one hour for separation due to low magnetic prosperities. 
Overnight separation is recommended for commercial dispersed MNPs under 30 nm in 
diameter. In order to decrease separation time, metal alloy MNPs, such as CoFe2O4, 
PtFe2O4, and MnFe2O4, were bio-functionalized for bacterial separation as well as 
biomedical applictions.16 Multifunctional magnetic nanoprobes have also demonstrated to 
simultaneously separate and detect bacterial cells. For example, antibody-modified 
Fe3O4/TiO2 core/shell magnetic nanoprobes were used to separate and detect Salmonella 
strains.17 Wang et al. reported the use of antibody-conjugated AuNRs decorated with 
Fe3O4 MNPs, including Fe3O4-AuNR-Fe3O4 nanodumbbells and a Fe3O4-AuNR 
necklace, for multiple pathogenic bacteria detection.10 
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IMS can be a useful tool for separating bacteria from complex matrices, such as 
food.  Capture efficiency, antibody cost, and total assay time are the main challenges for 
the implementation of IMS in low-resource settings. 
 
Figure 2.4 Magnetic separation of bound bacteria on the magnetic nanoprobes from 
unbound bacteria in the supernatant. (Where, CFUoriginal is the total number of bacteria 
cells present in the initial sample, CFUsupernatant is the number of bacteria cells which 
remained unbound to the magnetic nanoprobes, and CFUMNPs is the number of bacteria 
cells bound to magnetic nanoprobes.) 
 
2.4 Aptamer-Based Detection of Bacteria Cell 
Aptamers, consisting of single stranded nucleic acids (ssDNA or RNA), offer 
several advantages over the antibody-based recognition elements for the capture of 
bacterial cells. Aptamers are low-cost, chemically stable, and can be synthesized at a 
large scale. Due to their small size (typically 3-5 nm), aptamers can exhibit high binding 
affinity for target bacterial cells, resulting in a decrease in the overall detection limit. 
Aptamers can be designed for a variety of target bacteria using Systematic Evolution of 
Ligands by Exponential enrichment (SELEX), and have a three-dimensional 
configuration to bind epitopes on the surface of bacterial cells.18 During the process, a 
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large DNA library is added into a solution containing bacterial cells and incubated. The 
unbound DNA is then separated from bacterial cells, and bound DNA is eluted and 
amplified via PCR. The SELEX process is then repeated until the DNA has a high 
affinity for the target bacterial cells. During the synthesis process, aptamers can be 
functionalized with –SH, -NH2, and -COOH groups, providing an easy way to 
immobilize aptamers to nanomaterials.  Aptamer use in both fluorescence and SERS-
based detection methods will be described in this section. 
2.4.1 Fluorescent Nanoprobes 
Fluorescent nanomaterials are advantageous over common fluoropheres due to 
their large extinction coefficients and high photostability. Thus, the utilization of 
fluorescent nanoprobes has opened a new area for advanced fluorescence analysis and 
imaging. In addition to their high photostability, fluorescent nanomaterials with narrow 
and size tunable emission spectra allow researchers to precisely label target bacterial 
cells. Most importantly, fluorescent nanoparticles with differing colors, modified with 
varying recognition elements can be used to detect various types of bacterial cells 
simultaneously.  
Based on fluorescence resonance energy transfer (FRET), nanomaterials, such as 
AuNPs and GO, can serve as fluorescence quenchers to detect bacterial cells. Aptamers 
conjugated with fluoropheres can interact with quencher nanomaterials, turning off the 
visible fluorescence via FRET. In the presence of the target bacterial cells, the aptamers 
recognize the bacterial cells and release from the surface of the nanomaterial quencher. 
The resulting increase in fluorescence is used to quantify the concentration of bacterial 
cells (Figure 2.5a). By employing this principle, Duan et al. used a FAM-aptamer/GO 
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complex as a nanoprobe to detect S. typhimurium with a dynamic range from 103 to 108 
CFU·mL-1 and a detection limit of 100 CFU·mL-1.19 Furthermore, Zuo et al. applied 
aptamer-functionalized graphene oxide nanoprobes in a microfluidic biochip to detect 
Lactobacillus acidophilus (Figure 2.5b,c).20 The limit of detection was determined to be 
11 CFU·mL-1, within the assay time of 10 minutes.  
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Figure 2.5 (a) Schematic illustration of graphene oxide sensing platform for the detection 
S. typhimurium (Bacteria cell concentration can be detected by turning on the 
fluorescence signal after the aptamer is bind to target bacteria cells). (b) Schematic 
representation of the PDMS/paper hybrid microfluidic chips for one step pathogenic 
bacteria detection. (c) Illustration of the pathogenic bacteria detection principle inside the 
microfluidic channels.  
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2.4.1.2 Fluorescence Nanomaterials for Labeling 
The combination of aptamers and fluorescent nanomaterials as a fluorescence 
label has been used in several studies. Because the bacterial surface contains numerous 
possible binding moieties such as polysaccharides, proteins, and flagella, Kim et al. used 
a cocktail of aptamers with various targets to detect E. coli cells (Figure 2.6a).21 As 
shown in Figure 2.6b, a mixture of aptamers resulted in a higher fluorescence signal than 
did any single aptamer used, suggesting that a cocktail of aptamers could enhance the 
sensitivity for the detection of bacterial cells. Their report indicated that an 18-fold lower 
limit of detection was achieved using a cocktail of aptamers to detect E. coli bacterial 
cells when compared with a single aptamer. 
The ability to detect multiple bacteria types simultaneously is advantageous in 
many fields including medical diagnostics, food safety, and environmental monitoring. 
Researchers have demonstrated the ability to perform multiplex detection using several 
aptamer-nanoprobe combinations during a single assay. Duan et al. reported dual-color 
aptamer-conjugated fluorescent nanoprobes to simultaneously label and detect S. 
typhimurium and S. aureus.22 In the presence of target bacterial cells, the fluorescent 
nanoprobes attached to target bacterial cells, providing fluorescence readout using a 980 
nm laser. This proposed method had a good dynamic range of 101-105 CFU·mL-1 and 
excellent detection limit of 5 CFU·mL-1 for S. typhimurium cells and 8 CFU·mL-1 for S. 
aureus cells. The same researchers used aptamer-conjugated, dual-color quantum dots to 
simultaneously detect Vibrio parahaemolyticus and Salmonella typhimurium.23 
Fluorescence-based nanoprobes containing aptamers show good promise for multiplex 
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and sensitive detection of bacteria.  However, their use in complex matrices may result in 
quenching of the fluorophores.  
 
Figure 2.6 (a) Schematic illustration of single enhancement by cocktail aptamers for 
bacteria cells detection. (b) Fluorescence intensity of bacteria cell suspensions obtained 
after the fluorescence nanoprobes labeled with single, double, and triple aptamers. 
 
2.4.2 SERS-Based Nanoprobes 
Since initial reports of surface-enhanced Raman scattering (SERS) in 1964, 
metallic nanoparticles have attracted increasing attention for SERS-based detection of 
chemical and biological agents.24 The vibrational or rotational transitions on the Raman 
spectrum corresponding to specific molecular structures on the surface of bacterial cells, 
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providing a set of chemical fingerprints. The fingerprint spectra are helpful in 
distinguishing different types of bacterial cells. The Raman signals of bacterial cells, 
which are normally very weak, can be selectively and sensitively enhanced using 
plasmonic metal nanomaterials modified with recognition elements. This modification 
allows for the detection of low bacteria concentrations. The enhancement factors for 
SERS are generally attributed to a combination of electromagnetic and chemical 
mechanisms. The chemical mechanism is responsible for SERS enhancement by 
nanoprobes, explained by the interaction between the electrons from the target bacterial 
cells and the metal nanomaterials.25  
The basic principle behind aptamer-SERS for the detection of bacterial cells 
involves the utilization of aptamer-conjugated nanomaterials with numerous “hotspots”, 
providing a strong SERS signal. Both the aptamer and the nanoprobes are labeled with 
Raman reporter molecules. On the aptamer-based Raman nanoprobes, the aptamer can 
specifically bind to target bacterial cells. The Raman reporter molecules are then used to 
quantify the concentration of bacterial cells. Ravindranath et al. demonstrated a cross-
platform approach to simultaneously detect three pathogens using three aptamer-
conjugated nanoprobes modified with different Raman reporter molecules.26 The total 
detection time was less than 45 minutes, and a detection limit of 103 CFU·mL-1 was 
obtained. Similarly, a AuNRs-enhanced SERS aptasensor has also been developed for the 
simultaneous detection of S. typhimurium and S. aureus.27 As shown in Figure 2.7a, 
AuNPs were labeled with Raman reporter molecules and two types of aptamers as 
nanoprobes for the detection of bacterial cells. Here, MNPs were also modified with two 
types of aptamers to capture and concentrate S. aureus and S. typhimurium cells. As 
 19 
shown in Figure 2.7b, the peaks at 1333 cm-1 and 1582 cm-1 indicate the presence of S. 
aureus and S. typhimurium, respectively. The intensity at the specific peaks from the 
Raman reporter molecules contributed to the low detection limit of 35 CFU·mL-1 for S. 
aureus and 15 CFU·mL-1 for S. typhimurium. 
SERS-based detection of bacteria through aptamer nanoprobes has shown 
selective and sensitive results. The need for SERS equipment may hinder widespread 
usage of this method in low-resource settings.  Compared to antibodies, both fluorescent 
and SERS aptamer-based nanoprobes present a low-cost solution to more expensive 
antibodies.    
 
Figure 2.7 (a) Schematic illustration of the aptamer-conjugated nanoprobes for 
simultaneous detection of S. aureus and S. typhimurium based on SERS reporter 
molecules on AuNPs. (b) The Raman spectra of reporter molecules indicating the present 
of S. aureus and S. typhimurium in detection solution. 
 
2.5 Bacteriophage-Based Detection of Bacteria Cell 
The disadvantages of antibodies and aptamers, which include batch-to-batch 
variations, robustness in complex matrices, and relatively high cost, have led to research 
towards alternative biorecognition elements. Bacteriophages, also known as phages, are 
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bacteria-infecting viruses consisting of nucleic acid, protein capsid, and tail fibers. The 
tail fibers serve as recognition elements which can specifically recognize and bind to 
receptors on the surface of target bacterial cells. Depending on the particular phage, the 
bacteria host range can be either narrow or broad. The sizes of most phages are 
approximately 100 nm, which makes them ideal to be used as bio-nanomaterial probes 
for bacteria detection. In addition to their target specificity, another key feature of phages 
is their ability to distinguish viable versus inactive host bacterial cells. This is because 
phages can only replicate and express enzymes within viable bacterial cells.28 The 
specificity of a phage-based detection system requires careful host-range screening of 
phage libraries. This has allowed the development of detection systems specific for 
Escherichia coli, Vibrio cholera, Bacillus anthracis, and Listeria monocytogens. These 
phage-based detection assays are advantageous because they are rapid, sensitive, specific 
to host bacterial cells, low-cost to produce, and they detect only viable cells. Also, it is 
relatively easy and inexpensive to synthesize and purify phage, providing a new platform 
to detect bacteria. Thus, bacteriophages offer significant advantages when considering 
solutions for bacterial cell detection. 
2.5.1 Phage Lysis Assays-Based Detection 
Phages are obligate intracellular parasites, which can only replicate within target 
bacterial hosts.28 The phage amplification assays are illustrated in Figure 2.8. Following 
attachment to a suitable host cell, the phage will take over the cell’s machinery to 
replicate DNA, synthesize proteins, and finally lyse the host cells to release the replicated 
virus. The released phage can then find another suitable host cell and initiate a new 
infection cycle. At the end of incubation, the number of phages can be quantified using 
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conventional plating methods. The increased number of phages in solution can be used to 
calculate the concentration of target bacterial cells. Based on phage amplification assays, 
some commercial diagnostic kits have been available for the detection of S. aureus, 
Yersinia pestis, and Mycobacterium tuberculosis. Although low detection limits have 
been demonstrated, these methods are time and labor consuming. Phage amplification 
assays have been combined with other technologies, such as mass spectrometry, enzyme-
linked immunosorbent assay (ELISA), and PCR to decrease the total detection time.29-30 
For example, Martelet et al. developed a highly sensitive strategy for rapid and 
unambiguous detection of viable E. coli.29 The amplified phages were quantified using 
mass spectrometry combined with liquid chromatography. Their results indicated a limit 
of detection as low as 1 CFU·mL-1 for viable E. coli in food matrices following an 8 hour 
infection. Furthermore, the advantageous properties of phage amplification-based assays 
can be utilized to detect bacteria without producing resistant bacteria, and also be used to 
determine antibiotic resistance. 
 
Figure 2.8 Schematic illustrations of bacteriophage replication assays. 
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After the phage infection cycles, the intracellular components are released from 
the host cell and can be used as an indicator for the target bacterial cells. Some examples 
of intracellular components include β-galactosidase, adenosine triphosphate (ATP), and 
adenylate kinase. The enzymatic activity of phage-mediated released β-galactosidase was 
quantified using colorimetric, electrochemical, and chemiluminescent strategies. Derda et 
al. reported a colorimetric method to detect 50 CFUs of E. coli cells in 1 Liter of water in 
less than 4 hours.31 After adding luciferase and luciferin, the released ATP produced a 
bioluminescence signal. Their reports indicated the detection of E. coli and S. newport 
(selected as Gram positive and gram negative bacteria models) with a detection limit of 
103 CFU within 1 hours and 2 hours, respectively.32 Amperometric detection of 
Enterobacteriaceae cells in river water was performed, and reached a limit of detection at 
5 × 104 CFU·mL-1 with an incubation of 2 hours, and 10 CFU·mL-1 after a pre-
enrichment of 7 hours.33 Although phage lysis assays can produce a low limit of detection 
within a short time, a background signal is difficult to avoid. Thus, advanced technology 
combined with phage lysis assays need to be developed for future studies.  
2.5.2 Engineered Phage replication assays 
Engineered phages based on genetic engineering technologies are able to transfer 
genes of interest into specific target bacteria, which then express and amplify the gene 
product. This amplification allows for rapid and robust detection of bacteria. Therefore, 
engineered phages provide a potential low-cost tool for specific, rapid, and sensitive 
detection of bacteria. In order to reduce the background signal and decrease the variations 
between different bacteria strains, phage components (e.g. capsid proteins, nucleic acid) 
have been labeled with fluorescence using genetic engineering to act as a bio-nanoprobe 
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for bacterial cell detection. Due to the relatively large surface area of capsid proteins, 
phage heads labeled with a fluorescent tag can increase the sensitivity. A common 
fluorescent tag is green fluorescence protein (GFP), which is added on the small outer 
capsid protein on the phage head.34 Recently, engineered phages carrying an enzymatic 
reporter gene have attracted increasing attention for bacterial cell detection. Firefly 
luciferase, the most commonly used enzyme, has been reported to detect various bacterial 
cells.35 In addition, T7 phages were engineered to carry alkaline phosphatase or tobacco 
etch virus protease gene, generating phage-based platform for bacteria detection. 36-37  
Edgar et al. reported a rapid and simple method to detect E. coli (Figure 2.9).38 
The T7 phage was engineered to express biotinylation peptide on the phage capsid 
proteins. During the phage infection cycle for bacteria cell detection, the biotinylation 
peptide is biotinylated inside the host bacterial cells. Streptavidin-coated quantum dots 
were used to label biotinylated phages for fluorescent quantification. The detection limit 
of E. coli cells was shown to reach as low as 10 bacterial cells per milliliter, which had a 
100-fold amplification of readout signal over the background within 1 hour.  This method 
helps solve the issue of background signal interference commonly seen with phage lysis 
assays.  
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Figure 2.9 (a) Schematic representation of bacteria detection using engineered T7 phages 
labeled with quantum dots via streptavidin-biotin interaction. (b) Western blot analysis of 
T7biotin and T7control phage particles. 
 
2.5.3 Phage-Nanomaterial Hybrids  
Other methods include replacing antibodies with phages on magnetic beads, and 
phage-coating magnetic beads in combination with other technologies. These methods 
have successfully detected several pathogenic bacteria.39 Taking advantage of the high 
surface-to-volume ratio of MNPs, Chen et al. fabricated T7 phage-based magnetic FeCo 
nanoprobes for bacteria separation.14 The FeCo MNPs were functionalized with 
streptavidin, which were bound by biotinylated T7 phages via streptavidin-biotin 
interaction. The TEM micrographs of streptavidin coated FeCo MNPs, biotinylated T7 
phages, and T7 phage-MNPs complex were shown in Figure 2.10a-c. Their reports 
indicated similar bacteria capture efficiency between antibody- and phage-conjugated 
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nanoprobes (Figure 2.10g). However, phages served as nanoprobes provided some 
advantages, including relative ease of production, ability to distinguish between viable 
and inactivated bacterial cells, and controllable host range. Moreover, phage-conjugated 
nanoprobes take the advantage of reliable specific binding, low-cost production at a large 
scale, as well as high tolerance to temperature and pH. 
 
Figure 2.10 TEM images of (a) FeCo MNPs, (b) negatively stained T7 phage particles, 
(c) positively stained biotinylated phage bound to streptavidin-coated FeCo MNPs, (e) 
antibody-conjugated MNPs attached on the surface of bacteria cells, (f) phage-modified 
magnetic nanoprobes attached on the surface of bacteria cells. (g) Comparison the 
capture efficiency between antibody- and phage-conjugated magnetic nanoprobes. 
 
2.6 Electrostatic Interaction-Based Sensing of Bacteria Cell 
Unlike antibodies, aptamers, and bacteriophages, the selective recognition-based 
sensing is to non-specifically detect bacterial cells by the reversible binding between 
nanoprobes and target bacterial cells. Compared with specific recognition elements, the 
selective recognition can be used to detect and recognize multiple target bacterial cells.40 
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Such selectivity-based approach can provide a sensing platform to either detect a wide 
range of bacterial strains or recognize an individual bacterial cell strain.  
2.6.1 Selective Detection of Bacteria Cell 
Positively charged nanomaterials have the ability to bind to negatively charged 
protein surfaces through electrostatic interactions. Several nanomaterials, such as gold 
nanoparticles, carbon nanotubes, and graphene oxide, have been reported to interact with 
enzymes, inhibiting enzymatic activities. Based on the reversible interaction, the recovery 
of enzymatic activity can be used as an indicator of bacterial cell concentration. Li et al. 
synthesized positively charged graphene oxide to inhibit β-galactosidase (β-gal) activity 
for the colorimetric detection of bacterial cells and sensing of antibiotics.41 Also, 
enzymatic activity has been reversibly inhibited by positively charged 
polyethyleneimine-coated AuNPs to detect Gram-positive or Gram-negative bacterial 
cells in drinking water as low as 10 CFU·mL-1 via simple visual readout.42 
Rotello and coworkers has reported the synthesis of cationic AuNPs for the 
selective detection of bacterial cells in differing detection formats.43-45 Because of 
electrostatic interactions, the enzymatic activity of β-gal was inhibited by cationic AuNPs 
which featured quaternary amine head groups. In the presence of bacterial cells, AuNPs 
were released from the AuNPs/β-gal complex and bound to the surface of the bacterial 
cells, resulting in the recovery of enzymatic activity (Figure 2.11a). The colorimetric 
results and absorbance intensities versus bacterial concentrations are shown in Figure 
2.11b,c, indicating an obtained detection limit of 100 CFU·mL-1.43 Furthermore, the 
detection system was inkjet-printed on paper for low-cost diagnostics in contaminated 
drinking water. As seen in Figure 2.11d, the AuNPs/β-gal complex and colorimetric 
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substrates were co-patterned on the paper strip. After dipping the test strip into a bacterial 
solution for 5 minutes, E. coli XL1 (102 CFU·mL-1) and B. subtilis (103 CFU·mL-1) can 
be detected (Figure 2.11e).44 After the β-gal is released from the AuNPs/β-gal complex, 
the enzyme activity can also be monitored and quantified using electrochemical 
strategies. Electrochemically, E. coli and S. aureus can be detected with high sensitivity 
(102 CFU·mL-1) within 1 hour.45 While selective detection can provide rapid and 
sensitive detection of bacteria, these methods need to be validated in complex matrices, 
such as food. 
 
Figure 2.11 (a) Schematic illustration of selective detection of bacteria cells based on the 
switchable interaction of positively charged AuNPs and negatively charged enzyme.  (b) 
Photograph and  (c) absorbance intensity at the wavelength of 595 nm of the detection of 
bacteria cells with different concentrations. (d) Inkjet printing scheme for the fabrication 
of test strips. (e) Photograph of inkjet printed test strip for the Gram positive and Gram 
negative bacteria detection. 
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2.6.2 Array-Based Sensing of Bacteria 
Array-based sensing attracts considerable attention as a detection platform, 
because of its independent selectivity for complex target bacterial cells. Typically, a set 
of selective nanoprobes recognizes a set of target bacterial strains, generating patterns. 
Much like mammalian olfaction, the generated patterns, formed by differential 
interactions between nanoprobes and bacterial cells, can serve as fingerprints to identify 
and analyze the bacterial cells.40 As shown in Figure 2.12a, nanoprobe A-G were 
interacted with bacteria 1-4, resulting in multiple responses to form array-based patterns. 
The bacterial strains can be identified by analyzing the multiple response data using 
principle component analysis (PCA) or linear discriminant analysis (LDA).40 
Philips et al. have demonstrated an array-based sensing of bacteria within minutes, 
using AuNPs and poly (para-phenyleneethynylenen) (PPE), a fluorescent polymer.46 The 
AuNPs were modified with three different quaternary amine functional head groups, 
which can quench the fluorescence polymers based on FERT. In the presence of bacterial 
cells, the fluorescent polymers are released from the AuNPs/PPE complex (Figure 2.11b). 
Due to the differential binding affinities between different AuNPs and bacterial cells, 
multiple fluorescence readouts were recorded and analyzed using LDA. As shown in 
Figure 2.12c, each cluster represents one kind of bacteria. Twelve kinds of bacterial 
strains, including Gram-negative and Gram-positive bacteria, can be detected and 
discriminated. Interestingly, the same strains with different substrains (e.g. E. coli BL21, 
E. coli XL1, and E. coli DH5) can also be differentiated. Due to the complex compound 
in biofilms, it is channeling to discriminate biofilm bacteria strains. Based array-based 
sensing, Li et al. have developed a rapid and effective multichannel sensor to 
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discriminate bacteria strains in biofilms.47 The results indicated that the multichannel 
sensor could also identify nonpathogenic and pathogenic bacteria. While the array-based 
sensing provided a powerful platform to analyze multiple targets at the same time, more 
research is needed to assess viability in complex matrices. 
 
Figure 2.12 (a) Schematic illustration of the signal pattern generation using array-based 
sensing. (b) Schematic representation of the detection of bacteria strains using turning-on 
fluorescence array sensors. (c) Canonical score plot for the fluorescence array patterns 
calculated using LDA. 
 
2.7 Other recognition element-based detection of bacteria 
Some small molecules, including carbohydrates, lectin, and vancomycin, have 
emerged as important recognition elements on nanomaterials for the detection of bacteria. 
Due to their excellent stability to temperature or pH variations, these small molecules 
have attracted attention for mediating interactions between nanomaterials and bacterial 
cells. These small recognition elements have a strong affinity to bind a broad range of 
bacterial cells, which are suitable for the detection of unanticipated bacteria. Compared 
with antibodies or aptamers, these small molecules have much higher recognition element 
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densities on the surface of nanomaterials, providing strong affinity for the capture of 
bacterial cells. 
Carbohydrates (polysaccharides or oligosaccharides) have been modified on 
nanoparticles as recognition elements to capture bacterial cells. EI-Boubbou et al. have 
used mannose- and galactose-functionalized MNPs to discriminate the E. coli strain.48 
After carbohydrates are conjugated with proteins or lipids, the formed glycoproteins or 
glycolipids can also recognize and bind to specific bacterial cells. Lectin, the most typical 
glycoprotein, can bind to N-acetyl glucosamine of peptidoglycan on the surface of 
bacteria. Lectins have previously been bound within columns to capture bacteria in a 
liquid sample. Additionally, they have been bound to magnetic beads to continuously 
remove microorganisms from blood.49 Furthermore, vancomycin, a glycopeptide 
antibiotic, have been functionalized on MNPs to trap Gram positive or negative bacterial 
cells.50 While these methods allow for strong binding events, there is potential for 
interference from food matrices. 
2.8 Conclusions 
The development of advanced nanoprobes is important for the detection and 
sensing of pathogenic bacterial cells. Recognizing the importance of the interaction 
between recognition element and bacterial cells is helpful to design specific detection 
strategies to capture bacterial cells. The choice of suitable nanomaterials provides 
sensitive signal transduction methods to detect bacterial cells. Selection of the proper 
combination of recognition elements and nanomaterials enable researchers to build 
diagnostic platforms for a broad purpose. In this review, we have summarized how the 
recognition elements on nanomaterials as nanoprobe to detect bacteria. Although many 
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researchers report using these nanoprobes, more sensitive and specific nanoprobe-based 
detection assays (being able to detection bacteria with 1 CFU·mL-1) are compelling of 
need to advance this rapidly changing area.   Additionally, research is needed to examine 
the feasibility of these nanoprobes in applicable matrices, such as food, medial, and 
environmental samples. The most important factors to consider when fabricating a 
nanoprobe include manufacturability, reproducibility, assay time, cost, specificity, 
sensitivity, and ability for on-site detection of bacterial cells. The advancement of 
nanoprobes for bacterial cell detection has the ability to impact multiple industries, such 
as food safety, clinic diagnostics, and environmental monitoring. However, the potential 
toxicology of nanomaterials on human and environmental health should be taken into 
consideration when designing for daily use.  
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CHAPTER 3 
 
DETECTION OF ESCHERICHIA COLI IN DRINKING WATER USING T7 
BACTERIOPHAGE-CONJUGATED MAGNETIC PROBE 
 
3.1 Introduction 
In developing countries, the lack of clean drinking water and sanitation is a 
critical health issue.112-114 The World Health Organization (WHO) estimated that 1.5 
million children die from diarrheal diseases every year, 88% of which were caused by 
unsafe drinking water supply and inadequate sanitation.112 One of major causes is from 
contamination water with Escherichia coli (E. coli).115 The E. coli in drinking water 
mostly comes from domestic wastewater discharge or other sources such as livestock 
manure.  
The Food Safety Modernization Act now required the testing of agricultural water 
for “generic E. coli”. Although many of these organisms are non-pathogenic, they serve 
as indicators for bacterial contamination. A current method for bacteria detection in 
drinking water is through the detection of an indicator strain such as E. coli. A commonly 
used method for indicator strain detection relies on selective growth media that contains 
inhibitors to prevent unwanted bacteria from growing. The more widely used method for 
E. coli detection in drinking water is determination of β-galactosidase activity.81-83, 89, 115-
117 This enzyme is released by the bacteria and indicates the ability of the organism to 
metabolize lactose. For routine monitoring of agricultural water, generic E. coli has been 
used as an indicator of water quality, with a sample limit of 235 CFU·100 mL-1 and a 
rolling 5-sample mean of 126 CFU·100 mL-1.118 However, the analysis procedure takes at 
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least 18 hours from sample to results.18 Therefore, there exists an urgent need to develop 
an inexpensive, rapid and reliable method to detect E. coli in drinking water. 
Bacteriophages (phages) are viruses that infect bacteria, and are widely 
distributed in our environment. Phage can specifically recognize and attach to a host 
bacterial cell, commandeering the host cell’s “machinery” into producing large quantities 
of new phage virons. At the end of an infection by a lytic phage, the host cell is 
enzymatically lysed and the newly assembled phage virons are released into the 
environment to find additional hosts.72 There is renewed interest in phages as detection 
probes due to their specificity, speed of infection, and ability to introduce novel genetic 
material into the cell.119, 120 Since phages can only replicate within a viable host, phage-
based detection schemes are able to distinguish between live and inactivated bacteria.69 
This strategy is an improvement over DNA or antibody based detection assays,121 as their 
targets may still be present (nucleic acids or epitopes) even if the pathogen of concern has 
been successfully inactived, thus resulting in a false positive. As a result, many studies 
have attempted to leverage phage-based schemes to detect pathogenic bacteria, such as 
Staphylococcus aureus, Yersinia pestis and Mycobacterium tuberculosis.89, 122-124 
β-Galactosidase (β-gal), encoded by the lacZ gene, is an important enzyme for the 
growth of E. coli. β-Gal catalyzes the hydrolysis of lactose into galactose and glucose, 
thus providing a carbon source for E. coli growth. Isopropyl β-D-thiogalactopyranoside 
(IPTG) is known to induce the expression of β-gal during the growth of E. coli. Several 
previous studies have used IPTG induced expression of β-gal in electrochemical 
detection schemes for E. coli in drinking water.82, 116, 125, 126 The detection limit of several 
similar techniques for E. coli strains are summarized and compared in Table 3.1. While 
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sensitive, these detection methods require advanced instrumentation and professionally 
trained operators, making their use problematic in resource-limited settings. Colorimetric 
assays, that can be visually interpreted represent an alternative method, is more amenable 
to resource-limited settings. Furthermore, recent developments in digital imaging and 
image processing greatly simplifies the quantitative analysis of colorimetric assays and 
avoids the use of advanced and expensive instruments.127, 128  
Table 3.1 Summary and comparison of techniques for detection of E. coli stains. 
 
Detection method Detection time Sensitivity Reference 
Electrochemistry Less 1 hour 2×106 CFU·mL-1 116 
Electrochemistry 6-7 hours 20 CFU·mL-1 116 
Electrochemistry 2 hours 6×105 CFU·mL-1 82 
Electrochemistry 7 hours 10 CFU·mL-1 82 
Luminescent 8 hours 40 CFU·mL-1 83 
Luminescent 12.5 hours 1 CFU·mL-1 89 
Colorimetry Less 4 hours 50 CFU·mL-1 81 
 
In this study, T7 bacteriophage covalently conjugated to carboxylic acid-modified 
magnetic beads through an amide bond were used to capture and infect target bacteria (E. 
coli BL21). The captured E. coli were then separated prior to lysis from the initial sample 
using a magnetic. Following separation, the E. coli-phage-bead complex was placed in 
buffer and allowed to lyse as part of the natural infection cycle. The lysis released β-gal 
from the capture cells, which then catalyzed the hydrolysis of a colorimetric substrate to 
provide visual signal (Figure 3.1). The bacterial concentration in drinking water was then 
quantified by measuring the color change via camera-generated RGB values. 
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Figure 3.1 Schematic representation of detection of Escherichia coli in drinking water 
using T7 bacteriophage-conjugated magnetic probe. Three steps were involved: (i) 
Separation of E. coli from drinking water using T7 bacteriophage-conjugated magnetic 
probe to; (ii) T7 bacteriophage infection of Escherichia coli and the consequent release of 
β-gal. (iii) β-gal catalyzed CPRG hydrolysis to produce colorimetric readout. 
 
3.2 Experimental Section 
3.2.1 Chemicals and Materials 
2-(N-Morpholino)ethanesulfonic acid (MES) hydrate, 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide 
(NHS) were purchased from Acros Organics (Morris Plains, NJ). Bovine serum albumin 
(BSA), isopropyl β-D-1-thiogalactopyranoside (IPTG), glutaraldehyde, sodium chloride, 
potassium chloride, sodium phosphate dibasic, potassium phosphate monobasic, tryptone, 
yeast extract and agar were purchased from Fisher Scientific (Fair Lawn, NJ). 
Chlorophenol red-β-D-galactopyranoside (CPRG) was purchased from Roche 
Diagnostics (Indianapolis, IN). Magnetic beads were Dynabeads® MyOneTM carboxylic 
acid from Invitrogen (Oslo, Norway). The filter with 0.45 µm pore size (Millex) and 
syringe with 20-mL volume (BD) were also purchased from Fisher Scientific (Fair Lawn, 
NJ). All chemicals were reagent grade and used as received. Aqueous solutions were 
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prepared using Mill-Q water with 18.2 mΩ·cm at 25 °C from Thermo Scientific 
(Asheville, NC). All media, buffer and plastic/glassware were sterilized by autoclaving at 
121 °C for 30 min. 
3.2.2 Instrumentation.  
Scanning electron microscopy (SEM) images were obtained using an FEI SEM 
Magellan (Hillsboro, OR) with current of 13 pA and voltage of 1 kV. The absorbance 
intensities were recorded using a UV-Vis spectrophotometer from Biotek (SynergyTM 
2,Winooski, VT). The photographs were taken using a portable iPhone 5 camera from 
Apple (Cupertino, CA).  
3.2.3 Preparation of T7 Bacteriophage-Conjugated Magnetic Beads (Phage-MBs) 
The T7 phage-MBs were prepared according to a previously reported method 
with a slight modification.129 The amine groups on the surface of T7 phages were 
covalently bound to carboxylic acid modified magnetic beads by an amide linkage. The 
magnetic beads (100 µL, 10 mg·mL-1) were washed three times with MES buffer and 
then suspended in MES buffer (1 mL). EDC (200 µL, 20 mg·mL-1) and NHS (100 µL, 20 
mg·mL-1) were added and incubated for 30 min at room temperature with gentle 
agitation. The magnetic beads were washed three times with ice-cold phosphate buffered 
saline (PBS) buffer to remove excess EDC and NHS, and finally dispersed in PBS buffer 
(1 mL). Then T7 phage stock in PBS buffer (100 µL, 1011 PFU·mL-1; PFU, plaque 
forming units) was added to the beads and agitated overnight at 4 °C. The magnetic beads 
were washed at least three times with PBS buffer to remove excess T7 phage. The beads 
were then resuspended in PBS buffer containing 0.1% BSA (1 mL, 1 mg·mL-1) and 
incubated for 2 hours at 4 °C to block residual sites on magnetic beads. Finally, the T7 
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phage-MBs were stored in PBS buffer (1 mL) at 4 °C for further use. For SEM images, 
the samples were incubated in 2 % glutaraldehyde solution overnight at 4 °C, then 
dehydrated using serially diluted ethanol solution.  
The phage titer was enumerated following standard plaque assay procedure. 
Briefly, the stock solution of T7 phage-MBs was 10-fold diluted into serial 
concentrations. 100 µL of each solution was added into a sterile tubes containing 200 µL 
of a fresh overnight bacteria culture at room temperature. Then, approximately 3 mL of 
melted top agar (50 °C) were added into these tubes. The mixtures in the tubes were 
immediately poured in a standard luria broth (LB) agar plates. The plates were placed in 
the incubator at 37 °C until clear plaques were seen. 
3.2.4 Bacteria Culture 
Prior to each experiment, a single colony of E. coli BL21 was selected from an 
previously streaked LB plate and grown in LB broth overnight at 37 °C with 200 rpm 
agitation. The culture was then centrifuged at 6000 g for 2 min, and resuspended in in 
PBS buffer. This centrifugation step was repeated for a total of three times. This bacterial 
working stock solution was then serially diluted into desired concentrations for further 
usage. Each concentration of bacteria was plated on LB agar plate to confirm the viable 
counts (CFU·mL-1).  
3.2.5 Colorimetric Detection of E. coli BL21 Using T7 Phage-Conjugated Magnetic 
Probes 
The working E. coli stock was serially diluted into the following concentrations 
using PBS buffer: 104, 105, 106 and 107 CFU·mL-1. Aliquots (1 mL) of each 
concentration were added to sterile centrifuge tubes for detection. PBS buffer was used 
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for control experiment. Next, T7 phage-MBs (100 µL, 1 mg·mL-1) were added to the 
above samples. The samples were incubated for 15 min at room temperature, and the 
bacteria were separated using magnet for 2 min. The supernatant was removed and the 
bacteria-bead complex was washed three times with PBS buffer. The beads were then 
resuspended in PBS buffer (220 µL) and CPRG (30 µL, 8 mM). Samples were incubated 
for 2 hours at 37 °C. 200 µL of each sample were transferred into 96-well plate. The 
absorbance values were determined using a UV-Vis spectrophotometer at a wavelength 
of 595 nm. Following color development, a digital image of each sample was taken. The 
circles with same diameter were selected from each well to represent each sample. The 
RGB channel and value were obtained using ImageJ 1.48 V (Wayne Rasband, Madison, 
WI). 
3.2.6 Detection of E. coli in Drinking Water 
The drinking water sample was collected from water fountains at University of 
Massachusetts, Amherst. A filter with 0.45 µm pore size was used to prevent large 
substances/aggregates (including most of the bacteria) in drinking water from interfering 
the interactions within our system. An aliquot of this pre-filtered water was used as 
negative control and another three were inoculated with E. coli BL21 to a final 
concentration of 100 and 1,000 CFU·mL-1. 100 µL of each water sample was pipetted 
into sterile flasks, and combined with 0.9 mL of LB liquid medium containing 0.2 mM 
IPTG. The mixtures were incubated for 5-8 hours at 37 °C with 200 rpm agitation prior to 
measurement.  
After incubation for a predetermined time, T7 phage-MBs (100 µL, 1 mg mL-1) 
were added into the negative control and two drinking water samples, respectively. 
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Following incubation for 15 min, the bacteria were separated with a magnet. The 
magnetic bead-bacteria complex was washed three times. The samples were re-suspended 
in PBS buffer (220 µL) and CPRG (30 µL, 8 mM) and incubated at 37 °C for 2 hours. 
The absorbance values were measured using 96-well plate reader at a wavelength of 595 
nm. All experiments were performed with independent triplicates. 
3.2.7 Statistical Analysis 
All data is presented as mean ± standard deviation (SD) from at least three 
replicates. The t-test was conducted to determine if each set of data was significantly 
different from the corresponding control set. One star (*) signifies a difference (0.01 < p 
< 0.05) and two stars (**) represented the significant difference (p < 0.01) between the 
two compared sets of data. 
3.3 Results and Discussion 
3.3.1 Covalent Immobilization of T7 phage on Magnetic Beads and Separation of E. 
coli BL21 
Phage-conjugated magnetic beads (phage-MBs) are a better performing 
alternative to immunomagnetic separation (IMS) for the separation of bacteria.130, 131 For 
example, P22 phage has been reported to separate Salmonella using tosyl-activated 
magnetic beads.97 T4 phage coated Dynabeads have also been used to increase the 
sensitivity of E. coli K12 detection.129 In this study, the magnetic beads were coated with 
carboxylic acid. The size of the magnetic beads was approximately 1 µm. During the 
immobilization reaction, water-soluble EDC and NHS were used to create an amide bond 
between carboxylic acids of magnetic beads and primary amines on the phage. BSA was 
used to block remaining active sites in order to avoid non-specific binding between the 
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magnetic beads and target bacteria. The attachment of T7 phage on magnetic beads was 
evaluated using scanning electron microscopy (SEM) and plaque assays. The 
microscopic characterization of non-immobilization and immobilization of T7 phage are 
shown in Figure 3.2a-d. The carboxylic acid modified magnetic beads had a smooth shell. 
Following immobilization, the T7 and BSA coated beads appear to have a more uneven 
surface suggesting a surface coating has been achieved. Given the initial phage 
concentration of (2.5 ± 0.4) × 1011 PFU, the number of magnetic particles 7 × 107 
magnetic beads, and the number of phage (1.2 ± 0.5) × 1011 PFU remaining in the 
aspirated conjugation solution, we estimated the number of phage immobilized on each 
particle was approximately 1,871 PFU. Furthermore, T7 phage-MBs were able to initiate 
phage infection in E. coli BL21, as demonstrated by plaque assays, indicating successful 
conjugation of active T7 phage. The T7 phage-MB solution was tittered to contain (5.7 ± 
0.2) × 107 PFU·mL-1 of phage on appropriately 7 × 107 beads·mL-1. The difference 
between the number of phage captured and that tittered was due to the fact that each bead 
will act as “infective center” and produce a single plaque on a lawn of bacteria, despite 
having >103 PFU phage bound to it. 
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Figure 3.2 SEM images of (a) and (b) carboxylic acid coated magnetic beads, (c) and (d) 
T7 bacteriophage-conjugated magnetic beads, (e) E. coli BL21 cells and (f) E. coli BL21 
cells attached to T7 bacteriophage-conjugated magnetic beads through tail fiber. 
 
T7 phage specifically attaches to E. coli strains through recognition of 
lipopolysaccharide (LPS) as a receptor by the phage tail fiber protein.132, 133 The binding 
between the tail fiber protein and lipopolysaccharide on the bacteria is quite strong and 
irreversible, allowing for the bacterial separation from complex matrices using phage-
MBs. This binding of T7 phage-MBs to E. coli cells was also characterized using SEM. 
Figure 3.2e shows an SEM image of unbound E. coli BL21 while E. coli BL21 bound by 
T7 phage-MBs was achieved (Figure 3.2f). As shown in Figure 3.2f, T7-phage MB 
bound to single and multiple bacterial cells can be observed, as well as bacterial cells 
bound by multiple T7-phage MBs. 
3.3.2 Optimization of Detection Conditions 
E. coli BL 21 was harvested following an overnight growth at 37 °C. The culture 
was centrifuged and the bacterial pellets were washed three times with PBS buffer, and 
then resuspended in 1 mL of PBS. The suspension was serially diluted to achieve three 
concentrations: 105, 106 and 107 CFU·mL-1 in PBS buffer. PBS buffer was used as 
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negative control in the detection experiments. The β-gal activity of different 
concentrations of E. coli BL21 was determined by absorbance using CPRG as the 
colorimetric substrate. The absorbance of 200 µL samples in a 96-well plate was 
measured at a wavelength of 595 nm.  
 
Figure 3.3 Colorimetric response of released β-gal from E. coli BL21. (a) Detection of β-
gal activity from E. coli BL21 cells (0, 105, 106 and 107 CFU·mL-1) after incubated with 
phage or phage free buffer for 0, 1 and 2 hours. (b) Detection of β-gal activity from E. 
coli BL21 cells (0, 105, 106 and 107 CFU·mL-1) after incubated with CPRG solution (0, 2, 
4, 6, 8, 10 and 12 mM) at 25 °C and 37 °C. Error bars represent the standard deviation of 
a minimum of three replicates. 
 
T7 phage is a lytic phage resulting in bacterial cell lysis occurs at the end of 
infection cycle. The lysis of the infected cells results in the release of intracellular 
components, including β-gal, into the sample solution. To determine the concentration of 
β-gal released from T7 lysed bacteria cells, varying concentrations of bacteria (0, 105, 106 
and 107 CFU·mL-1) were either incubated with 30 µL of a 1.37 × 108 PFU mL-1 of T7 
phage or a phage-free solution at 37° and the absorbance was measured at 0, 60 and 120 
minutes. This colorimetric method was able to detect β-gal activity from phage-lysed 
cells when the initial cell concentration was 106 CFU·mL-1 after 60 minutes and 105 
CFU·mL-1 after 120 minutes. For comparison, this resulted in one log increase in 
sensitivity, respectively, when compared to the phage free control (Figure 3.3a). β-Gal is 
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a common intracellular enzyme and therefore solutions without phage infection were able 
to generate a weak colorimetric signal. This signal could be explained by the release of β-
gal into solution by natural cell lysis or the diffusion of CPRG across the cell membrane 
into the bacteria cells.82, 134, 135 As seen from Figure 3.3a, the absorbance increased with 
the increase of incubation time due to increased substrate utilization. A reaction time of 2 
hours was selected as optimal for the enzymatic reaction. 
Additional parameters for the colorimetric readout were optimized. The effect of 
temperature on the colorimetric detection was first studied using 25 and 37 °C. A greater 
colorimetric response was observed at 37 °C against 25 °C. This is not surprising as 37 
°C is known to be an optimal temperature for E. coli growth, T7 phage replication, as 
well as for the β-gal enzymatic reaction.82, 136 Additionally, phage adsorption has been 
shown to be relatively temperature independent. This would allow for a more reliable 
separation (vs. antibodies) in resource-limited settings.137 The concentration of 
colorimetric substrate was also an important factor influencing the absorbance. Increasing 
concentrations of E. coli were incubated for 2 hours at 37 °C with various concentration 
of CPRG solution (0-12 mM). The absorbance increased with increasing the 
concentration of CPRG and tended to level off after a concentration of 8 mM (Figure 
3.3b). Hence, a CPRG concentration of 8 mM was selected for further enzymatic 
experiments. 
Reaction conditions for all additional tests were thus performed using: 1.37 × 108 
PFU of T7 phage and 8 mM of CPRG at 37° for 2 hours, which allowed an efficient 
phage infection and enzymatic reactions to generate enough colorimetric signal. 
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Simultaneous addition of phage and CPRG was used to allow the enzymatic reaction to 
produce a faster colorimetric signal.83, 136 
3.3.3 Analytical Performance of E. coli BL21 Using T7 Bacteriophage-conjugated 
Magnetic Beads 
Under optimal conditions, T7 phage-MBs were introduced to detect different 
concentrations of E. coli BL21 cells. T7 phage-MBs were able to capture and infect 
bacteria cells, subsequently releasing β-gal into the sample solution. Different 
concentrations (104, 105, 106 and 107 CFU·mL-1) of bacteria cells were incubated with T7 
phage-MBs for 15 minutes. PBS buffer was used as negative control. After separation 
and three-time washing, CPRG was added and the mixture was incubated for 2 hours. 
The T7 phage MBs were separated for 2 minutes using a magnet (Figure 3.4a) and the 
clear supernatant was transferred into a 96-well plate to obtain the absorbance readout. 
The red color of the enzymatic product increased with the increasing bacterial 
concentration, and a concentration of 1 × 104 CFU·mL-1 produced a signal that can be 
distinguished visually (Figure 3.4b). The absorbance recorded at the wavelength of 595 
nm showed the same trend with increased bacteria concentrations (Figure 3.4c). Based on 
the absorbance, we could reproducibly detect bacteria concentration at 1 × 104 CFU·mL-1 
(p < 0.05), which corresponds with the visual results. The use of the magnetic beads has 
several benefits for detection. First, they allow for the concentration of bacterial cells, 
thus improving detection. Second, they allow for the separation of the bacteria from 
matrices like: milk, orange juice, turbid water and so on, that would otherwise interfere 
with colorimetric assays.81, 83  
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Figure 3.4 (a) Photographs of bacteria detection at different concentrations before and 
after magnetic separation. (b) Photograph of colorimetric response and (c) absorbance 
upon different bacteria concentrations. Error bars represent the standard deviation of a 
minimum of three replicates. 
 
Smartphone-based technology has become increasingly more popularly for use in 
analytical diagnostics. Erickson and his co-workers developed a smartphone platform to 
quantify vitamin D levels and detect pH change in saliva and sweat.138, 139 Multi-analyte 
tests based on colorimetry have also been successfully performed using smartphone 
devices.140 After obtaining an image from the smartphone, a corresponding app can 
analyze the RGB values and report the analytical results immediately. Such technology 
allowed the quick test in low-resource settings such as remote parts of Africa, South 
America and Southeast Asia which might be lacking professional laboratory facilities.5, 6, 
141-143 In this study, images were taken using an iPhone 5 built-in camera immediately 
following the incubating for 2 hours. By analyzing original image (Figure 3.5a) using 
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ImageJ software, the images for red, green and blue channels were obtained (Figure 
3.5b). The values for each RGB channel were plotted with bacteria concentration (Figure 
3.5c), which also confirmed that a bacterial concentration of 1 ×104 CFU·mL-1 could be 
detected (p < 0.05).144  
 
Figure 3.5 Schematic illustration of the RGB values to analyze β-gal activity released 
from different concentrations of E. coli BL21 cells. (a) Image of colorimetric response of 
β-gal activity released from different concentration. (b) Red, green and blue channels 
from original image (a) to different concentration processed using ImageJ. (c) Values of 
red, green and blue channels obtained from original image (a) to different concentration 
of E. coli BL 21 cells. Error bars represent the standard deviation of a minimum of three 
replicates. 
 
The specificity of the proposed assay was evaluated using common pathogenic 
bacteria strains as competitors, including Salmonella enterica (S. enterica), 
Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa (P. aeruginosa). The 
bacteria concentration of each strain in single or mixed competitor solutions was 106 
CFU·mL-1. A significant change in color and absorbance was observed only with the 
present of E. coli cells (Figure 3.6a-b). These results demonstrated this approach has a 
good specificity towards E. coli. 
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Figure 3.6 (a) Photographs and (b) absorbance of specificity of the T7 phage-conjugated 
magnetic probes against E. coli, S. enterica, S. aureus, P. aeruginosa, S. enterica + E. 
coli, S aureus + E. coli, P. aeruginosa + E. coli and mixture# at concentration of 106 
CFU·mL-1 (mixture# represents a mixture of E. coli, S. enterica, S. aureus and P. 
aeruginosa). 
 
3.3.4 Detection of Bacteria in Drinking Water with a Pre-enrich Step 
E. coli in drinking water are ideally well below the 1 × 104 CFU·mL-1 limit of the 
colorimetric test. To overcome this hurdle, we investigated using a pre-enrichment step to 
allow for bacterial growth, subsequently followed by our previously described assay. 
Water samples were collected from a local water fountain at the University of 
Massachusetts, Amherst. Different concentrations of bacteria were inoculated into LB 
liquid medium in the present of IPTG, which was a molecular mimic of CPRG. IPTG can 
trigger the transcription of lac gene in bacteria cells to express more β-gal.82, 116, 145, 146 
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IPTG cannot be hydrolyzed by β-gal and its concentration would remain constant in all 
experiments. Based on the visual images, a 10 CFU·mL-1 concentration of bacteria could 
be detected after a pre-enrichment of 6 hours while a pre-enrichment of 8 hours provided 
stronger visual signal (Figure 3.7a). As seen in Figure 3.7b, 10 CFU·mL-1 bacteria can be 
detected after pre-enrichment for 5 hours (p < 0.05). The reproducibility of the 
colorimetric assays to detect 10 CFU·mL-1 bacteria in drinking water was evaluated. The 
absorbance of 10 replicates was compared to the control (0 CFU·mL-1). All ten replicated 
resulted in an absorbance outside at least one standard deviation of the control, indicating 
that the proposed assays have the ability to detect low bacteria concentration in drinking 
water (Figure 3.7c). 
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Figure 3.7 Detection of E. coli in drinking water using T7 bacteriophage-conjugated 
magnetic probe. (a) Photographs and (b) absorbance of detecting bacteria concentrations 
after 5-8 hours of pre-enrichment. (c) Detection of E. coli at 10 CFU·mL-1 after 5 hours 
of pre-enrichment for 10 times (the solid line represents the average of absorbance of the 
control (0 CFU·mL-1) while the dashed lines represent the standard deviation. 
 
3.4 Conclusions 
Here, we show the successful use of T7 bacteriophage-conjugated magnetic beads 
to detect low levels of E. coli in drinking water. The T7 phage can specifically recognize 
 50 
and bind to Escherichia coli and the magnetic beads are used to separate and concentrate 
the bacterial cells from drinking water. After concentration and separation, phages will 
infect and lyse the host cells, resulting in the release of β-gal. The released enzyme can 
then be readily detected using a colorimetric assay. Compared to antibodies, which are 
used in standard immunomagnetic separation (IMS), T7 phages are low-cost, animal-free, 
and can be easily produced.97, 130 Another benefit to using T7 phage for bacterial 
separation is their broadly infect E. coli with minimal additional specificity,147, 148 which 
can allow us to detect an entire genus or species, a range which would be difficult to 
achieve with antibodies. Although there are strains to known to be resistant, solutions to 
be resistance has been identified.148, 149  
Using this proposed strategy, we were able to detect E. coli at a concentration of 1 
× 104 CFU·mL-1 in 2.5 hours. 10 CFU·mL-1 of E. coli in drinking water can be detected 
after pre-enrichment for 6 hours. Meanwhile, the high specificity towards E. coli and 
reproducibility of this approach has been demonstrated experimentally.  The assay has 
been designed to allow portability with the use of minimal equipment. This will allow the 
rapid determination of E. coli concentrations in water in settings where proper 
laboratories are not available. Future work will focus on translating this assay into a 
portable, rapid and low-cost test strips that are suitable for use in resource-limited setting. 
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CHAPTER 4 
 
BACTERIOPHAGE-BASED NANOPROBES FOR RAPID BACTERIA 
SEPARATION     
 
4.1 Introduction 
Advances in rapid bacteria detection methods have enabled improvements in 
speed, sensitivity and specificity in fields such as medical diagnostics, biowarfare 
detection, food safety, water quality and environmental monitoring. Technologies such as 
surface plasmon resonance (SPR)9, surface enhanced Raman scattering (SERS)150, 
electrochemical detection,107, 151 field effect transistor biosensors (FET) and quartz crystal 
microbalance (QCM)114, 152 are examples of emerging detection methods, which require a 
relatively clean sample in a small volume to achieve enhanced sensitivity. Unfortunately, 
such methods typically require a significant sample purification or preparation step prior 
to analysis. Analysis of complex samples (containing non-target lipids, proteins, 
carbohydrates, inhibitors, or other interferents) remains a unique challenge to utilizing 
such high sensitivity detection methods. Stevens and Jaykus suggested that an ideal 
separation method should 1) separate the analyte from the sample, 2) remove any 
possible inhibitors to a downstream detection system, and 3) reduce the sample size while 
maintaining a high capture efficiency of bacteria.153  
Immunomagnetic separation (IMS) is a common separation method in which 
magnetic beads tagged with analyte-specific antibodies are incubated with the analyte. 
When a magnet is placed near the sample tube, the beads (on which the analyte is bound) 
are pulled toward the magnet and the remaining liquid sample can be aspirated. IMS 
beads (typically 1-5 µm in diameter, onto which antibodies for a range of bacterial 
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analytes are conjugated) are commercially available from several companies. While this 
method is widely used, improvements to the capture efficiencies and cost would allow the 
method to become more utilized. Recently, magnetic nanoparticles (MNPs) have 
attracted attention in various fields such as biomedicine, drug delivery, and diagnostics 
due to their unique magnetic properties.41, 154, 155 Magnetic nanoparticles have been 
reported to efficiently separate E. coli O157:H7 in ground beef35, 36 and Listeria 
monocytogenes from both nutrient broth and milk samples156. Unfortunately, traditional 
iron oxide nanoparticles require extended periods of time to separate due to slow particle 
velocities. 
Bacteriophages, also known simply as phages, are viruses which infect specific 
bacterial cells. Phages have the ability to very strongly and specifically bind to target 
bacteria.68, 133 They are able to recognize a bacterium, infect it, and lyse it releasing 
hundreds to thousands of replicated phages in the process. Detecting bacteria using 
engineered phages by fluorescent labeling of phage nucleic acid157 and phage 
components158, phage-integrated colorimetric, fluorescent, and bioluminescent reporter 
genes70 and phage-integrated green fluorescent protein159 has shown promising results. 
The use of antibodies for separation can result in inconsistencies due to batch to 
batch variations. The relatively high cost of antibodies has led to research towards 
alternative biorecognition elements such as aptamers.160, 161 Unlike antibodies and 
aptamers, phages are relatively easy and inexpensive to synthesize and purify. Due to the 
extremely strong binding affinity,137 phage have recently been used as low-cost 
biorecognition elements for bacteria.133, 162 The host range of bacteriophages can be either 
extremely wide or narrow allowing for isolation of an entire genus or species.163 The 
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phages are also more stable than antibodies with regards to temperature, pH and ionic 
strength.164 
The challenge in using infective bacteriophages as recognition elements for 
separation lies in the infection cycle of the particular phage. The complete infection cycle 
can last as little as 25 minutes and results in lysed bacteria. Although this could be ideal 
for downstream genetic analysis such as PCR, if the bacteria have not been separated 
from the sample solution before cell lysis, the process would fail. Therefore the 
combination of bacteriophages and magnetic nanoparticles would require separation 
speeds much faster than those offered by iron oxide nanoparticles which require a 
significant separation time.  
In this paper, we have bound T7 bacteriophage on magnetic nanoparticles for the 
purpose of separating E. coli from a liquid solution. For the nanoparticles, mixed metal 
oxide (FeCo) magnetic nanoparticles containing 30% cobalt (w/w) were used as core 
materials. The cobalt allowed improved separation velocities as compared to iron oxide. 
The magnetic nanoparticles were coated with a silica shell, onto which streptavidin was 
immobilized for subsequent conjugation of biotinylated T7 bacteriophage and antibodies. 
The nanoscale phage magnetic probes were used to separate E. coli K12 at concentrations 
ranging from 102 to 107 CFU mL-1.  
4.2 Experimental Section 
4.2.1 Synthesis of Oleic Acid Protected FeCo MNPs 
The oleic acid protected FeCo MNPs were synthesised according to reported 
methods with some modifications.165, 166 Fe(acac)3 (1 mmol, 0.3680 g), Co(acac)2 (2 
mmol, 0.5355 g), and 1,2-hexadecanediol (3 mmol, 0.9675 g) were placed into a three-
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neck round bottomed reaction flask with dibenzyl ether (50.0 mL). The reaction mixture 
was stirred for 30 minutes under flowing nitrogen gas to allow the removal of air. The 
mixture was then slowly heated to 100 °C and kept at this temperature for 10 minutes. 
The surfactants, oleylamine (4.25 mL) and oleic acid (4.00 mL) were added into reaction 
flask and the reaction mixture was then heated to 200 °C for 20 minutes. Following the 
brief incubation, the reaction mixture was heated to reflux (~300 °C) for 60 minutes. 
During this process, the solution color changed from purple to black, indicating the 
formation of FeCo MNPs. The black solution was then cooled down to room temperature 
and the particles were precipitated using ethanol (20 mL) with centrifugation at 7500 x g 
for 10 minutes. The particles were then washed three times with a mixture of ethanol and 
hexane (3:1, V/V). Finally, the FeCo MNPs were dispersed in hexane until use.  
4.2.2 Preparation of Silica-Coated FeCo Core/Shell MNPs  
The silica-coated FeCo core/shell MNPs were prepared using a modification of a 
previously reported method.167 Polyoxyethylene(5)nonylphenyl ether (7 mmol, 3.0 g, 
Igepal CO-520) was dispersed in cyclohexane (50.0 mL). Next, dried FeCo MNPs (10 
mg) were transferred into cyclohexane (5.0 mL) and briefly sonicated. The two 
cyclohexane solutions were mixed until a clear solution formed. Ammonium hydroxide 
(25%, 0.5 mL) was added to form a clear brown reverse microemulsion. Lastly, 
tetraethylorthosilicate (30 µL, TEOS) was added, and gently agitated for 48 hours at 
room temperature. Methanol was added into the solution to remove the excess surfactant 
and the silica-coated FeCo core/shell MNPs were precipitated and washed three times 
using sonication and centrifugation with mixture of ethanol and hexane (1:3, V/V). The 
particles were then redispersed in ethanol until use. 
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4.2.3 Immobilization of Streptavidin on Silica-Coated FeCo MNPs 
The silica-coated FeCo MNPs (10 mg) were placed into a scintillation vial and 
washed sequentially with 5 mL each of a mixture of DI water and dimethyl sulfoxide 
(DMSO) (3:7, 5:5, 7:3, V/V). The particles were then washed three times in anhydrous 
DMSO to minimize the water content. N, N’-Carbonyldiimidazole  (1.0 mL, 10 mg mL-1, 
CDI in DMSO) was then added into the scintillation vial. Next, the vial was agitated for 2 
hours at room temperature. The MNPs were then washed three times with anhydrous 
DMSO to remove excess CDI, and washed using ice-cold sodium phosphate buffer 
solution (0.01 M, pH 7.4, PBS: 10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 
mM KCl). The MNPs were redispersed in PBS (5 mL, 0.01 M, pH 7.4), and streptavidin 
(500 µL, 1 mg mL-1 in PBS) was then added to the mixture. The conjugation solution was 
agitated for 12 hours at room temperature. Following conjugation, the MNPs were 
washed three times with PBS (0.01 mM, pH 7.4) using magnetic separation and stored at 
4 °C. 
4.2.4 Quantification of Biotin Capacity of Streptavidin Coated Nanoparticles 
Several volumes of streptavidin-coated nanoparticles solution (0, 50, 100, 150, 
200, 250 µL, 2 mg mL-1) were washed three times with acetate buffer (1 mL, 0.2 M, pH 
5.0, 166 mM sodium acetate trihydrate, 34 mM glacial acetic acid, 0.05% Tween 20), and 
finally dispersed in acetate buffer (1mL, 0.2 M). Following washing, d-biotin p-
nitrophenyl ester (100 µL, 10 mg mL-1 in DMSO, BNPE) was added and incubated for 30 
minutes with gentle agitation. The nanoparticles were then washed five times with above 
acetate buffer (1 mL, 0.2 M) to remove excess BNPE and finally dispersed in NaOH 
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solution (1 mL, 0.1 M). The BNPE bound to nanoparticles hydrolyzed and produced p-
nitryl phenol (yellow) which was quantified at 400 nm. 
4.2.5 Preparation of Biotinlyted T7 Bacteriophage 
T7 bacteriophage was previously genetically modified to express the 15 AA 
(GLNDIFEAQKIEWHE) biotin ligase (BirA) target on the capsid.95 The endogenous 
BirA within E. coli was able to conjugate biotin molecules to the phage capsid during 
replication. E. coli BL21 was grown overnight in Luria-Bertani (LB) broth (50 mL, pH 
7.4, 10 g L-1 tryptone, 5 g L-1 yeast extract, 10 g L-1 NaCl) at 250 rpm (37 °C). Following 
the overnight growth, the culture was reinoculated into fresh LB broth (35 mL), and 
agitated at 250 rpm for 3 hours at 37 °C. After the OD600 of the culture reached 0.6–0.8, a 
high titer biotin T7 phage lysate (5 µL, 1010 CFU mL-1) was added and the culture was 
again incubated for 1 hour at 37 °C until the solution cleared. Following the addition of 
salt (3 mL, 5 M NaCl), the culture was centrifuged at 7000 rpm for 10 minutes at 4 °C. 
The supernatant was stored at 4 °C until use. 
4.2.6 Preparation of Antibody or Phage Magnetic Nanoprobes 
Biotin-modified anti-E. coli K12 antibodies (10 µL, 4 mg mL-1) or biotinlyated T7 
phage (1 mL, 3.5×1010 CFU mL-1) were tagged onto streptavidin-coated nanoparticles (1 
mL, 1.8 mg mL-1). The solutions were incubated for 30 minutes with gentle agitation at 
room temperature. All nanoparticles were washed a minimum of three times with above 
PBS (0.01 M, pH 7.4) to remove unbound antibodies or phages. The nanoparticles were 
dispersed in PBS (1 mL, 0.01M, pH 7.4) and stored at 4 °C until use. 
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4.2.7 Estimation of the Capture Efficiency of Phage or Antibody Probes on Bacterial 
Separation 
E. coli K12 was inoculated into above LB broth (50 mL) and rotated at 250 rpm 
overnight at 37 °C. Antibody magnetic nanoparticles (100 µL, 1.8 mg mL-1) and phage 
magnetic nanoparticles (100 µL, 1.8 mg mL-1) were added into bacterial samples (1 mL, 
E. coli K12) in PBS (0.01 M, pH 7.4) with a range of concentrations (102-107 CFU mL-
1). The mixtures were incubated 30 minutes for antibody magnetic probes and 15 minutes 
for phage magnetic probes at 10 rpm at room temperature. The magnetic probes for E. 
coli K12 were separated and washed three times with PBS (0.01M, pH 7.4) by magnetic 
separation. The concentrations of E. coli in the original solution, E. coli (phage) in 
supernatant solution and E. coli (phage) on magnetic probes were counted using serial 
dilutions on LB plates (pH 7.4, 10 g L-1 tryptone, 5 g L-1 yeast extract, 10 g L-1 NaCl, 15 
g L-1 agar). 
4.3 Results and Discussion 
4.3.1 Preparation and Characterization of FeCo MNPs 
The challenge for using single domain MNPs in magnetic applications is the 
inherent aggregation which occurs even without an external magnetic field. However, 
superparamagnetic nanoparticles168 such as Fe3O4, γ-Fe2O3, cobalt oxides and mixed 
metal oxides (without inter-particle magnetic attractive forces) have been utilized in 
biomedicine, drug delivery and cancer research.42, 169 Karimi et al. reported that 7 nm 
FeCo MNPs have the highest saturation magnetization compared to the other MNPs with 
the same size.42 Mixed metal oxide FeCo MNPs were therefore utilized as core materials 
for our study. 
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Figure 4.1 (a) Transmission Electron Microscopy (TEM) image of oleic acid protected 
FeCo MNPs, and b) magnetization curve of FeCo MNPs at room temperature. 
 
Monodisperse FeCo MNPs capped with oleic acid were synthesized using 
previously reported procedures.165, 166 Briefly, surfactants were used to surround the iron 
and cobalt salts resulted in the formation of the initial monomers. When the 
supersaturated monomers were heated, they became a nucleation site for particle growth. 
Once cooled, the nanoparticles were able to be dispersed in a non-polar solvent such as 
hexane due to the hydrocarbon tail of the oleic acid cap. The size of FeCo magnetic 
nanoparticles was found to be 9.1 ± 2.3 nm in diameter (Figure 4.1a). In order to 
determine the magnetic behavior of FeCo MNPs, the magnetic hysteresis loops were 
performed at room temperature (T = 300 K) using a superconduction quantum 
interference device (SQUID). The FeCo MNPs were found to be superparamagnetic with 
zero coercivity. The saturated magnetization value of FeCo MNPs at room temperature 
was appropriately 59 emu g-1 (Figure 4.1b), which was similar to previously reported 
value.165 As seen in Figure 4.2, the X-ray photoelectron spectroscopy (XPS) analysis of 
MNPs was shown in -1, indicating the present of Fe (727 eV) and cobalt (787 eV). The 
FeCo MNPs were able to be separated from hexane with an external magnetic field. 
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Following removal of the magnetic field, the particles were able to be redisbursed with 
mild agitation. 
 
Figure 4.2 The XPS spectra of FeCo MNPs (black line) and silica coated FeCo MNPs 
(red line). 
 
4.3.2 Immobilization of Streptavidin on FeCo MNPs 
The steps to immobilize streptavidin on FeCo MNPs are shown in Figure 4.3a. In 
order to protect the mental core from the sample matrix, the FeCo MNPs were first 
coated with a silica shell170 which also served as a more suitable and convenient 
functionalizable surface. In this study, we prepared the silica-coated FeCo MNPs using a 
reverse microemulsion in cyclohexane. A non-ionic surfactant (Igepal® CO-520) was 
used to suspend the oleic acid-covered FeCo MNPs in aqueous NH3·H2O. The surfactant 
allowed the formation of a water layer on the nanoparticles for hydrolysis of TEOS. The 
optimal ratio of Igepal® CO-520 to NH3·H2O minimized the number of micelles which 
contained multiple FeCo nanoparticles in the core. The thickness of silica shell has 
previously been reported to be tunable from 2 nm to 100 nm.171 The thickness of silica 
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layers on FeCo MNPs which were used for this study was 9.0 ± 1.8 nm (Figure 4.3b). 
The present of silica shell was also confirmed using XPS analysis (Figure 4.2). The TEM 
image of streptavidin coated on FeCo MNPs is shown in Figure 4.3c. A thin layer of 
streptavidin can be identified on the surface of the MNPs. 
 
Figure 4.3 Functionalization magnetic nanoparticles. (A) A silica shell was synthesized 
from tetraethylorthosilicate (TEOS) which was then functionalized with streptavidin (SA) 
using carbonyldiimidazole (CDI). (b) Transmission electron micrographs of silica-coated 
FeCo MNPs. c) TEM images of streptavidin coated on MNPs (insets: streptavidin coated 
on MNPs at high magnification). 
 
This silica layer has the following advantages: 1) it allows convenient conjugation 
chemistries; 2) it provides a separation of the magnetic cores and reduces aggregation and 
3) it decreases non-specific absorption of biological species.172 
 61 
A common method used to immobilize proteins on the surface of nanoparticles is 
by covalent attachment using 3-aminopropyltriethoxysilane (APTES) and 
glutaraldehyde.173 However, Gopinath et al. compared several methods of surface 
modification and concluded that N, N’-Carbonyldiimidazole (CDI) provided an improved 
direct immobilization of molecules without an intermediate chemical linker.174 The 
method used to immobilize streptavidin on silica-coated FeCo MNPs in this study was 
shown in Figure 4.3a. The CDI was used to activate the silanol group on the surface of 
silica shell promoting conjugation to a primary amine on the streptavidin protein.  
4.3.3 Determination of Biotin Binding Capacity of Nanoparticles 
In this study, these nanoparticles were functionalized with streptavidin for the 
attachment of a biorecognition element (phages or antibodies). In order to fully cover 
nanoparticles with phages and antibodies, the biotin binding capacities on these 
nanoparticles were determined. Therefore, the total concentration of biorecognition 
elements was comparable across all treatments. A colorimetric measurement was 
performed to determine the biotin binding capacity of streptavidin on the nanoparticle. A 
solution of d-biotin p-nitrophenyl ester (BNPE) was reacted with nanoparticle solutions 
of varying immobilized streptavidin in the biotin binding sites. Following incubation, the 
magnetic nanoparticles were washed three times to remove unbound NBPE. In the 
present of NaOH, the bound BNPE was hydrolyzed to produce p-nitryl phenol (yellow), 
which was quantified at 400 nm (Figure 4.4a).175 The absorbance values of nanoparticles 
were compared to a standard curve (R2 = 0.998) of p-nitryl phenol (Figure 4.4b). Finally, 
the biotin binding capacity of streptavidin on magnetic nanoparticles was calculated 
using equation 1: 
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c = cVMW ×m ×10
9
      (1) 
In the above equation, C (nmol mg-1) refers to the biotin binding capacity of 
streptavidin-coated magnetic nanoparticles, c was the concentration of p-nitryl phenol 
(mg mL-1), V is the volume of hydrolyzed supernatant solution, MW is the molecule 
weight of p-nitryl phenol (g mol-1) and m is the weight of streptavidin-coated magnetic 
nanoparticles.175 The biotin binding capacity of streptavidin-coated nanoparticles is 
166.95 ± 12.87 nmol mg-1. This represented approximately 8 × 103 biotin binding sites 
per nanoparticle.  
 
Figure 4.4 (a) Schematic showing the mechanism to measure the biotin binding capacity 
and (b) biotin binding capacity of streptavidin-coated nanoparticles. 
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4.3.5 Biofunctionalization of Nanoparticles with Phages or Antibodies 
In this study, antibodies modified with biotin were conjugated to streptavidin-
coated magnetic nanoparticles. The TEM image of negative uranyl acetate stained biotin-
modified T7 phage without nanoparticles was shown in Figure 4.5a. Similarly, T7 
bacteriophages, which were genetically engineered to express biotin on the capsid176 was 
able to directly bind with streptavidin magnetic nanoparticles (Figure 4.5b). Following 
standardization of the biotin binding capacity of nanoparticles, the number of phages 
conjugated on nanoparticles was enumerated following standard plaque assay procedure, 
resulting in (1.50 ± 0.53) × 1010 PFU mg-1. Based on eleven TEM images, the phage-
MNPs complex was counted and one phage per magnetic nanoparticle accounted for 74% 
of all phage-MNPs complexes. Phages bounded with two or three nanoparticles were also 
found (Figure 4.5b). 
 
Figure 4.5 TEM images of (a) negative uranyl acetate staining of biotin T7 phage and (b) 
positive uranyl acetate staining of biotin T7 phage attached to streptavidin-coated FeCo 
MNPs. 
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4.3.6 Comparison of the Capture Efficiency between Antibody and Phage-
Conjugated magnetic Nanoprobes 
Typical IMS beads conjugated to antibodies for specific bacteria are 
commercially available from several companies.130, 131 By using nano-scale particles, the 
capture efficiency is increased. When used to capture E. coli O157:H7 in ground beef, a 
capture efficiency of over 90% was achieved.35 Similar results were found by Pappert et 
al. who calculated a 96 ± 6% capture efficiency of E. coli from a 106 CFU ml-1 culture.36 
In this study, the two magnetic nanoprobes (T7 phages and antibodies on magnetic 
nanoparticles) were used to separate E. coli K12 (range: 102 to 107 CFU mL-1) from 1 mL 
sample solution. Nanoparticles utilizing an antibody capture were incubated with the 
bacteria using standard protocols of 30 minutes with mild agitation. A shortened binding 
time was required for the T7 phages containing particles as 30 minutes could have 
resulted in lysis of bacteria. Therefore, the phage nanoparticles were incubated for only 
15 minutes prior to magnetic separation. Following hybridization, all nanoparticle 
variants were rapidly separated using an external magnet (Figure 4.6). The capture 
efficiency was calculated using the equations 2 and 3: 
 
CE1(%) = (1− NaNo
)×100%
     (2) 
 
CE2(%) = NbNo
×100%
     (3) 
Where, No is the total number of E. coli K12 cells present in the initial sample 
(CFU), Na is the number of E. coli K12 cells which remained unbound to the particles 
(CFU), Nb is the number of E. coli K12 cells bound to the particles (CFU).35 Due to 
aggregation of the separated nanoparticle/bacteria complex, quantification using standard 
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plating methods made CE2 (Equation 3) unreliable. This phenomenon has previously 
been reported with the magnetic separation of E. coli.35, 156 Therefore, the capture 
efficiency was reported using CE1 (Equation 2).  
 
Figure 4.6 Magnetic separation of bound bacteria on the magnetic nanoprobes from 
unbound bacteria in the supernatant (not drawn to scale). 
 
The separated nanoparticles and bacteria were imaged using transmission electron 
microscopy (TEM) (Figure 4.7a,b). The capture efficiency (CE1) of the two magnetic 
nanoprobes can be seen in Figure 4.7c. In order to determine the specific bind between 
the nanoprobes and E. coli cell, the negative control result of streptavidin coated MNPs 
was shown (Figure 4.7c). A similar capture efficiency between phage and antibody 
magnetic nanoprobes was obtained, indicating that phages produced easily and at low 
cost can replaced the commonly used antibodies for bacteria separation at nanoscale size. 
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Figure 4.7 TEM images of nanoprobes bound to E. coli K12: a) antibody-conjugated 
nanoparticles, b) phage-conjugated nanoparticles, e) antibody-conjugated microbeads and 
f) phage-conjugated microbeads, (c) and (f) comparison the capture efficiency between 
the two magnetic nanoprobes: phage magnetic nanoprobes (solid round line) and 
antibody magnetic nanoprobes (hollow round line), and phage magnetic microprobes 
(solid square line) and antibody magnetic microprobes (hollow square line). 
 
In order to further confirm that phages can be used as biorecognition elements for 
bacteria separation instead of antibodies, magnetic beads at microscale size was 
measured. The commercial streptavidin-coated magnetic microbeads modified with 
phages and antibodies were used to separate E. coli K12. Firstly, the biotin binding 
capacity of streptavidin-coated magnetic microbeads was measured using above-
mentioned method and 306.54 ± 26.04 nmol mg-1. In order to equal the biotin binding 
capacity at micro and nanoscale size, the amount of streptavidin-coated microbeads was 
normalized. Next, phages and antibodies were immobilized on these microbeads for 
bacterial separation. The TEM images of microbeads and bacteria were shown in Figure 
4.7d,e. Compared with antibody magnetic microprobe, phage magnetic microprobe 
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resulted in a higher capture efficiency (Figure 4.7f). Among all magnetic probes, the 
lowest capture efficiency was the current standard for IMS which used antibodies on 
microbeads. Phage-conjugated magnetic probe showed a promising tool for bacteria 
separation. 
4.4 Conclusions 
We have developed nanoscale T7 bacteriophage magnetic nanoprobes for the 
low-cost and efficient separation of bacteria from liquid sample. The capture efficiency at 
all bacterial concentrations (102-107 CFU mL-1) was not significantly different between 
the bacteriophage magnetic nanoparticles and antibody magnetic nanoparticle while 
using only half the incubation time for phage magnetic probes. Compared with traditional 
filtration, the key feature using magnetic nanoparticles modified as biorecognize 
elements is that they can specifically concentrate and separate target bacteria cell. It 
should also be noted that the application of phages as a detection nanoprobes provides 
many advantages over other molecular probes due to their relative ease of production, 
host specificity, ability to distinguish between viable and non-viable cells, and potential 
for rapid bacteria detection. Additionally, phages are highly stable to temperature, pH 
variations, organic solvents and degradation by proteases.177 
While most detection devices require small and relatively clean samples, many 
sample matrices such as food, soil and feces are inherently complex and contain 
inhibitors for downstream analytical tools such as PCR. In these cases, a sample 
preparation step becomes a necessary tool for reliable testing. Additionally, many 
organisms such as Listeria monocytogenes, Salmonella spp. and E. coli O157:H7 have a 
zero tolerance in food thus requiring the ability to detect a single organism in a 25 gram 
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sample. While typical protocols require an enrichment step to grow the organisms, this 
process takes hours to days and is therefore not suitable to all sample types such as fresh 
produce. Bacteriophages on magnetic nanoparticles represents an improved 
separation/concentration tool as compared to the current molecular biology standard, 
IMS. 
In order to eliminate the infectivity of toxicity of bacteriophage for bacteria 
separation, further studies will focus on conjugating ghost phage (able to bind, but not 
infect) on nanoparticles to better quantification of the separation ability for target 
bacterial detection.178 This will allow a fast and low-cost method to isolate and detect 
bacteria. Additionally, the separated bacteria would also undergo a natural lysis as part of 
the infection. This can allow access to the DNA for applications such as QPCR and 
therefore allow the determination of only viable organisms as infection would not occur 
in nonviable bacteria. 
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CHAPTER 5 
 
COLORIMETRIC DETECTION OF ESCHERICHIA COLI BASED ON THE 
ENZYME-INDUCED METALLIZATION OF GOLD NANORODS 
 
5.1 Introduction 
Due to their low infectious dose, bacterial infectious diseases result in approximately one 
third of all global deaths.7, 107 Accurate and early detection of bacterial pathogens can 
lead to immediate and effective treatment, which can prevent or curtail foodborne and 
waterborne pathogen outbreaks.16 However, many of the current gold-standard methods 
to identify pathogenic bacteria require at least 18 hours from sample to results.18 This 
creates an urgent need to develop rapid and reliable methods to detect bacteria in 
environmental, food, and water matrices. These methods are also necessary in resource-
limited settings.6, 130, 141, 179 A colorimetric assay that does not rely upon advanced 
instruments and skilled operators is the most promising method for rapid detection of 
bacterial pathogens. Furthermore, colorimetric methods linked to enzymatic reactions 
have been widely accepted for their practicality and simplicity.16, 105, 180 Enzyme-induced 
colorimetric detection of bacteria is based on monitoring and measuring a color change 
resulting from enzymatic activity via a biochemical reaction of corresponding 
substrates.105, 180, 181 Unfortunately, the enzyme-induced colorimetric detection do not 
have sensitive color change, and therefor can only serve as a rough estimation.182 Hence, 
a novel enzyme-induced colorimetric assay with high-sensitive color change is of great 
significance.  
Recently, plasmonic noble metal (gold and silver) nanomaterials-enabled colorimetric 
detection strategies have attracted a wide attention due to their rapid, sensitive, and 
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unique optical properties.31, 183, 184 Interparticle crosslinking or destabilized aggregation of 
plasmonic metal nanoparticles has been reported to detect DNA, cancer cells, heavy 
metal ions, and bacterial cells.31, 184 Compared with the similarly sized gold spherical 
nanoparticles, the gold nanorods (AuNRs) have been reported to perform better due to an 
inherently higher sensitivity to local dielectric environment.28, 29 AuNRs have two 
localized surface plasmon resonance (LSPR) peaks: the transverse LSPR peak and the 
longitudinal LSPR peak. The transverse LSPR band locates around 520 nm, and the 
longitudinal absorption band locates from visible to near-infrared (NIR) absorption band 
depending on the aspect ratio (AP, length divided by width) of AuNRs.180, 185-188 The 
longitudinal LSRP peak shifts to shorter wavelength (blue shift) with the increasing of 
AP.189 It has been demonstrated that depositing silver shell on the surface of AuNRs can 
change the AP of AuNRs, resulting in distinctive multicolor change.186, 190 The changes in 
color have been successfully utilized in an investigation into the affects of time and 
temperature on food freshness.186 Until now, this technique has not been applied to the 
detection of bacteria in clinic or food samples.  
In this work, we utilized enzyme-induced silver metallization on the surface of 
AuNRs for both high-resolution colorimetric monitoring and measurement of beta-
galactosidase (β-gal) activity. The sensing scheme of our proposed method incorporates 
β-gal for hydrolyzation of substrates into weak reduction agents, which can reduce silver 
ions to generate a silver shell on the surface of AuNRs. The decrease of AP resulted in 
the blue shift of the longitudinal LSPR peak of AuNRs and an obvious color change from 
light green to orange-red.  This proposed method was employed to detect Escherichia 
coli (E. coli) in aqueous solutions using β-galactosidase activity as a direct readout for E. 
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coli concentrations. The bacterial cells were infected with T7 bacteriophages (phages) in 
order to release β-gal for enzyme-induced colorimetric detection. A phage-based system 
was advantageous compared to an antibody-based platform because of their specificity 
for target bacterial cells, their ability to distinguish between live and dead cells, and their 
low cost.64, 69, 71, 96 The released β-gal induces a metallic silver deposition on the surface 
of AuNRs. β-Gal activity and the blue shift of the longitudinal LSPR peak was directly 
relative to the concentration of target E. coli cells. This enzyme-induced metallization 
colorimetric assay has the potential to be built into point-of-care devices for detection of 
bacterial concentration in low-resource settings. 
5.2 Experimental Section 
5.2.1 Chemicals and Materials 
Cetyltrimethylammonium bromide (CTAB), chlroauric acid trihydrate (HAuCl4), 
L-ascorbic acid (AA), poly (4-styrenesulfonic acid) (PSS), β-galactosidase (β-gal), p-
aminophenyl β-D-galactopyranoside (PAPG), α-chymotrypsin (ChT), glucose oxidase 
(GOx), alkaline phosphatase (PhosB), lipase (Lip), myoglobin (Mayo), and bovine serum 
albumin (BSA) were purchased Sigma Aldrich (Saint Louis, MO). Silver nitrate 
(AgNO3) was purchased from Acros Organics (Morris Plains, NJ). Sodium borohydride 
(NaBH4), hydrochloric acid (HCl), Ο-nitrophenyl-β-galactoside (ONPG) sodium chloride 
(NaCl), potassium phosphate monobasic, sodium phosphate dibasic, agar, tryptone, and 
yeast extract were purchased from Fisher Scientific (Fair Lawn, NJ). All chemical were 
used as received. Mill-Q (MQ) water with 18.2 MΩ·cm at 25 °C was used throughout the 
all experiments. 
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5.2.2 Synthesis and Coating of AuNRs.  
The AuNRs stabilized with CTAB were synthesized using the seed-mediated 
growth method.180, 186, 187 For seed solution, HAuCl4 solution (0.25 ml, 0.01 M) was 
added into CTAB solution (9.75 mL, 0.1 M) under magnetic stirring. The freshly 
prepared ice-cold NaBH4 solution (0.6 mL, 0.01 M) was then added quickly. The solution 
was aged for 2 hours at 30 °C before use. The growth solution was prepared by mixing 
HAuCl4 solution (2.0 mL, 0.01 M), AgNO3 solution (0.4 mL, 0.01 M), HCl solution (0.8 
mL, 0.1 M), and CTAB solution (40 mL, 0.1 M). AA solution (0.32 mL, 0.1M) was then 
added to reduce the gold salt. The seed solution (200 µL) was added until the growth 
solution became colorless. To grow the AuNRs, the mixture solution was kept at 30 °C 
overnight. The AuNRs were collected and washed by centrifugation (1000 ×g, 20 
minutes) and redispersion in Mill-Q water twice. PSS (0.5 mL, 10 mg mL-1) in NaCl 
solution (5 mL, 10 mM) was added and incubated for 30 minutes in room temperature.  
Excess CTAB and PSS were removed by centrifuging twice at 1000 ×g for 20 minutes. 
Finally, the AuNRs with transverse and longitudinal plasmon bands at 510 and 885 nm 
were suspended into Mill-Q water. The AuNRs solution was diluted with an expected 
absorbance intensity of approriately1.000 at 858 nm.  
5.2.3 AuNRs-Based Colorimetric Monitoring of β–gal Concentration 
Different concentrations of β-gal solution (25 µL) were added into PAPG solution 
(25 µL, 1.2 mM) in centrifuge tubes, respectively. The mixture solutions were gently 
agitated and incubated at 37 °C for 30 minutes. The enzymatic hydrolyses (50 µL) were 
added into detection solutions, which consisted of AuNRs solution (100 µL, Ab885 nm = 
1.0), AgNO3 solution (10 µL, 10 mM), and PB (100 µL, 10 mM, pH 7.4). The absorbance 
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spectra of the resulting solutions (200 µL) were recorded using UV-vis 
spectrophotometry with a wavelength range of 300-940 nm. The specificity to detect β-
gal was investigated using competing proteins (ChT, GOx, PhosB, Lip, Mayo, and BSA). 
5.2.4 Bacterial Culture and Bacteriphage 
The E. coli BL21 and T7 phage were used in this study. A single colony of E. coli 
was selected and added into lysogeny broth (LB) and grown overnight at 37 °C under 200 
rpm agitation. The E. coli stock was prepared by centrifugation at 6000 ×g for 2 minutes 
and resuspended in PB (10 mM, pH 7.4). The process was repeated for a total of three 
times. The concentration of E. coli cells was enumerated on a LB agar plate to confirm 
the visible counts (CFU·mL-1). The preparation and tittering of T7 phages were reported 
by our previous publications.40, 96 
5.2.5 Detection of E. coli Using AuNR-Based Colorimetric Assay 
The E. coli stock was serially diluted into varying concentrations using PB. Each 
concentration (25 µL) was added into sterile centrifuge tube containing PAPG solution 
(25 µL, 12 mM), phage solution (50 µL, appropriately 4.4 × 107 PFU·mL-1), and PB (150 
µL, 10 mM). In order to allow the phage infection and enzymatic reaction, the mixtures 
were gently agitated and incubated at 37 °C for 2 hours. The enzymatic hydrolyses (50 
µL) were added into detection solutions consisting of AuNRs solution (100 µL, Ab885 nm = 
1.0), AgNO3 solution (10 µL, 10 mM), and PB (100 µL, 10 mM). Finally, each produced 
color solution (200 µL) was measured using UV-vis spectrophotometry from 300 to 940 
nm. 
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5.3 Results and Discussion 
5.3.1 Sensing Mechanism of Enzyme-Induced Colorimetric Assay 
The principle of the AuNR-based colorimetric assay using enzyme-induced 
metallization is shown in Figure 5.1. In the absence of β-gal, the unhydrolyzed PAPG 
cannot reduce silver ions to metal silver. The color of the solution remains the color of 
AuNRs (light pink color). When β-gal is present, it converts PAPG into a reducing agent 
PAP, which in turn reduces silver ions. In the presence of AuNRs, the reduced metal 
silver coats the surface of AuNRs, resulting in different colors of the detection solution. 
The color of detection solution varies from light green to orange-red according to the β-
gal concentration. 
 
Figure 5.1 Sensing mechanism of enzyme-induced AuNR-based colorimetric assay for 
the monitoring and measuring of β-gal concentration. Three steps were involved: (i) β-gal 
converted PAPG into PAP serving as weak reducing agent, (ii) PAP reduced silver ions 
to metallic silver, and (iii) the AuNRs were coated with metallic silver, resulting in 
various colorful detection solutions. 
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5.3.2 Characteristics and Control Experiments for Enzyme-Induced Colorimetric 
Assay 
AuNR synthesis using different ARs with seed-mediated growth has been 
reported previously. 185, 191 In this study, AuNRs with an AR of appropriately 5.1 were 
used for colorimetric detection. The as-synthesized AuNRs had a length of 59.7 ± 8.3 nm 
and a width of 11.7 ± 1.4 nm. The AuNRs were coated with cetyltrimethylammonium 
bromide (CTAB), which positively charges them. This resulted in colloidal stability, 
prevented aggregation, and therefore, the AuNRs were well suspended in the Mill-Q 
water using CTAB as surfactant.192 The absorbance spectrum of AuNRs-CTAB shows 
transverse and longitudinal plasmon bands at 510 and 885 nm, respectively (Figure 5.2). 
However, AuNRs coated with CTAB were not stable in alkaline solution (pH > 7) due to 
the weak protection of CTAB.192 In phosphate butter (PB, pH 7.4), which is preferred in 
biosensing applications and enzymatic reaction107, 193, 194, the change in the absorbance 
spectrum of AuNR-CTAB indicated that the AuNRs were aggregating (Figure 5.2). 
Although increasing the CTAB concentration was helpful for AuNR stability in PB, 
excess CTAB also inhibited downstream reactions. In order to stabilize the AuNRs in PB, 
AuNRs-CTAB were coated with poly (4-styrenesulfonic acid) (PSS).195 The strong 
electrostatic attractive interaction between the positively-charged CTAB and negatively-
charged PSS allowed the formation of double-layer coating.196 The absorbance spectra of 
AuNRs-PSS in Mill-Q water and PB are shown in Figure 5.2. Compared with AuNRs-
CTAB in Mill-Q water, the transverse and longitudinal plasmon bands with a slight shift 
were observed. After adding β-gal into the PAPG, AgNO3, and AuNRs solution, the color 
change of solution was caused by the deposition of metal silver on the surface of AuNRs.  
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Figure 5.2 The UV-vis absorbance spectra of the AuNRs-CTAB in MQ water (black), 
AuNRs-PSS in MQ water (red), AuNRs-CTAB in PB (green), and AuNRs-PSS in PB 
(blue). 
 
In order to confirm the presence of a silver shell on the surface of AuNRs, the 
morphology of the AuNRs before and after enzyme-induced metallization was 
characterized using transmission electron microscopy (TEM). The resulting TEM images 
and energy-dispersive X-ray (EDX) elemental mapping images of AuNRs were shown in 
Figure 5.3a, b. Previous studies have reported that the metal silver were preferably 
deposited on the transverse direction (body side) of AuNRs.186, 197 In our study, the silver 
shell on the body sides of AuNRs was observed in Figure 5.3b. The deposition of Ag 
shell on the surface of AuNRs was further investigated using HRTEM-EDX. In Figure 
5.3a,b, the corresponding EDX Ag (red color) and Au (green color) mapping images 
confirmed also the coating of metal silver on the surface of AuNRs.  
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Figure 5.3 TEM images of AuNRs (a) before and (b) after silver deposition (their 
corresponding EDX elemental mapping images of silver and gold were displayed on the 
right of their TEM images). Control experiments of the enzyme-inducted metallization 
colorimetric detection. (c) UV-vis absorption spectra and (d) table of reagents added to 
each tube of (i) AgNO3 + PAPG + AuNRs, (ii) AgNO3 + β-gal + AuNRs, (iii) β-gal + 
PAPG + AuNRs, (iv) AgNO3 + β-gal + PAPG, (v) AgNO3 + β-gal + PAPG + AuNRs, 
and (vi) AgNO3 + AuNRs + PAP. 
 
Because the silver preferably deposited on the transverse direction of the AuNRs 
rather than the longitudinal direction, it resulted in the decrease of the AR of the nanorod 
structure. The lower AR the AuNR has, the greater blue shift of the longitudinal LSPR 
peak is observed in the absorbance spectrum. Moreover, compared with Au nanocrystals 
of the same shape and size, Ag nanocrystals showed a shorter plasmon resonance.182, 186 
Therefore, the enhanced absorbance intensity and blue shift of the longitudinal LSPR 
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peak were observed after enzyme-induced Ag metallization on the surface of AuNRs 
(Figure 5.3c).  
This sensing procedure was further tested with the following control experiments: 
(i) AgNO3 + PAPG +AuNRs, (ii) AgNO3 + β-gal + AuNRs, (iii) β-gal + PAPG +AuNRs, 
(iv) AgNO3 + β-gal + PAPG, (v) AgNO3 + β-gal + PAPG +AuNRs, and (vi) AgNO3 + 
AuNRs + PAP. The absorbance spectra of control experiments were shown in Figure 
5.3c. The blue shift of the longitudinal LSPR peak occurred in the presence of AgNO3, β-
gal, PAPG, and AuNRs. In the absence of β-gal and PAPG, enzymatic hydrolysis (PAP) 
caused a similar blue shift of the longitudinal LSPR peak, indicating that β-gal and PAPG 
solutions were key for the reduction of silver ions to form silver shell on the surface of 
AuNRs. Meanwhile, the color changes of AuNR solutions were observed (Figure 5.3d). 
These results demonstrated that our design has the ability to specifically detect β-gal 
concentration. 
5.3.3 Optimization of Experimental Conditions for Silver Deposition Reaction 
It is clear that β-gal hydrolyzed PAPG to generate PAP, which can reduce silver 
ions and generate Ag shell on the surface of AuNRs. The change in morphology of 
AuNRs resulted in the blue shift of the longitudinal LSPR peak and color change of 
detection solution. Therefore, the concentration of Ag ions and reaction conditions for 
enzymatic hydrolysis needed to be optimized for improved Ag deposition on the AuNR 
surface. Based on manufacturer suggestions, the enzymatic reaction was performed at 37 
°C. At this temperature, additional reaction parameters including AgNO3 concentration, 
PAPG concentration, PB concentration, and pH were optimized for further experiments. 
The blue shift of the longitudinal LSPR peak (Δλmax) was selected as standard for the 
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performance of silver deposition reaction. First of all, the silver ions concentration was 
optimized. A high concentration of silver ions can accelerate the reduction reaction, 
resulting in a thicker Ag shell on the surface of AuNRs (Figure 5.4a). However, high Ag 
deposits on the AuNRs bodies caused loss of overall nanorod structure, indicating that the 
AR of AuNRs was close to zero. In the absorbance spectrum, the longitudinal LSPR peak 
of AuNRs disappeared and a strong plasmon resonance wavelength of silver nanocrystals 
was observed (Figure 5.4b). Therefore AgNO3 concentration at 10 mM was selected as 
optimal for silver reduction reaction.  
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Figure 5.4 The experimental conditions for silver deposition reaction. The effects of 
silver-depositing AuNRs (a-b) AgNO3 concentration, (c-d) PAPG concentration, (e-f) PB 
concentration, and (g-h) pH. Error bars represent the standard deviation of three 
replicates. 
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Higher PAPG concentration could increase their hydrolysis opportunity by β-gal, 
increasing the blue shift of the longitudinal LSPR peak of AuNRs. The absorbance 
spectra of varying PAPG concentrations is shown in Figure 5.4d with blue shift of the 
longitudinal LSPR peak plotted against the PAPG concentration in Figure 5.4c. The blue 
shift of the longitudinal LSPR peak increased with the increasing of PAPG concentration 
and stabilized at a concentration of 1.2 mM. Therefore a PAPG concentration of 1.2 mM 
was adopted for following reactions.   
In order to optimize the PB solution for this procedure, varying PB concentrations 
and pH were studied. A higher base concentration in PB can tolerant the change after 
adding enzymatic substrate and AuNRs solutions. As shown in Figure 5.4e, the blue shift 
of the longitudinal LSPR peak tended to level off after a PB concentration of 10 mM, 
which was selected for the development of the colorimetric detection. The pH of the 
buffer also influenced the enzyme-induced silver deposition reaction greatly due to 
optimal pH for enzymatic reaction. As shown in Figure 5.4g, the blue shift in the 
longitudinal LSPR peak of AuNRs initially increased with the increasing of pH, and then 
decreased after pH of 7.4. Due to these data, a detection solution consisting of 10 mM 
AgNO3 and 1.2 mM PAPG in 10 mM PB (pH 7.4) was selected for further colorimetric 
experiments.  
5.3.4 Analytical Performance for Colorimetric Detection of β-gal Concentration 
Using the aforementioned optimal conditions, varying concentrations of β-gal 
were used to evaluate the sensitivity and dynamic range of the enzyme-induced 
metallization colorimetric assay. First, the β-gal solutions were incubated with PAPG 
solution to produce reducing reagent PAP. After incubation for 30 minutes, the 
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hydrolyzed PAP was added into the detection solution to reduce silver ions. We used the 
absorbance spectra to monitor the change of AuNRs in varying β-gal concentrations 
(Figure 5.5a). The longitudinal LSPR peak shifted from 885 nm to 520 nm, and the 
absorbance intensity of longitudinal LSPR peak increased with the increasing of β-gal 
concentrations. The blue shift of the longitudinal LSPR peak (Δλmax) was plotted against 
the β-gal concentration. As shown in Figure 5.5b, the Δλmax increased with the increasing 
of β-gal concentration, and a dynamic relationship between Δλmax and β-gal concentration 
in a range from 0.1 nM to 10 nM was observed. The limit of detection (LOD) of 0.128 
nM was calculated using 3σcontrol/slope, where σcontrol was the standard deviation of 
control samples, and the slope was from the linear range. As shown in Figure 5.5c, the 
detection solutions exhibited colors from light green to orange-red as compared to the 
control. The distinct multicolor changes can be easily identified visually or with a 
reader.127, 198  
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Figure 5.5 The colorimetric detection of β-gal concentration using enzyme-induced 
metallization of gold nanorods. (a) UV-vis absorption spectra, (b) the blue shift in the 
longitudinal LSPR peak (insert: linear range, the solid and dash lines indicates the 
average and ± 3 standard deviation of Δλmax of control samples), and (c) photographs of 
colorimetric assay toward various concentrations of β-gal. 
 
For comparison, conventional colorimetric assay for the detection of β-gal 
concentration using ONPG as enzymatic substrate was performed. As shown in Figure 
5.6a, the absorbance spectra of detection solutions indicated the absorbance wavelength 
at 405 nm had the maximum absorbance intensity (A405 nm). The absorbance at 405 nm 
versus β-gal concentration with ONPG as enzymatic substrate was plotted in Figure 5.6b. 
It was clearly observed that the absorbance intensity increased with the increasing of β-
gal concentration and leveled off after the β-gal concentration of 2 mM. The dynamic 
range of conventional colorimetric method was from 0.1 nM to 0.2 nM, which was 
narrower than that of our present colorimetric assay. Additionally, the limit of detection 
calculated using 3σcontrol/slope was 0.163 nM, which was also higher than that of our 
present colorimetric method. For the conventional method, the color change of the 
detection solution was from colorless to yellow (Figure 5.6c), which is difficult to 
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identify without machine assistance. In summary, these results indicated that the ability to 
monitor and measure β-gal activity was improved in limit of detection, dynamic range, 
and colorimetric output using our present assay.  
 
Figure 5.6 The colorimetric detection of β-gal concentration using the ONPG-based 
conventional colorimetric method. (a) UV-vis absorption spectra, (b) the absorbance 
intensity at the wavelength of 405 nm (insert: linear range, the solid and dash lines 
indicates the average and ± 3 standard deviation of absorbance intensity of control 
samples), and (c) photographs of colorimetric assay toward various concentrations of β-
gal. 
 
In order to evaluate the specificity of our present AuNR-based colorimetric assay 
for β-gal detection, control experiments were conducted using competing proteins [5 
nM], including, α-chymotrypsin (ChT), glucose oxidase (GOx), alkaline phosphatase 
(PhosB), lipase (Lip), myoglobin (Mayo), and bovine serum albumin (BSA). As shown in 
Figure 5.7a, an obvious blue shift of the longitudinal LSPR peak in the absorbance 
spectra was observed only in the presence of β-gal, and the Δλmax of competing proteins 
was also plotted (Figure 5.7b). In contrast to solutions with β-gal, we did not observe a 
change in color in the control experiments, (Figure 5.7b). Thus, these results revealed that 
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our present enzyme-induced silver metallization on the surface of AuNRs assay had 
specifically detects β-gal activity. 
 
Figure 5.7 The specificity of this proposed method for β-gal against common competing 
proteins (5 nM): ChT, GOx, PhosB, Lip, Mayo, and BSA. (a) UV-vis absorption spectra 
of the colorimetric assay toward various protein competitors. (b) The blue shift in the 
longitudinal LSPR peak of the specificity of β-gal against various protein competitors 
(insert: the corresponding photographs). Error bars represent the standard deviation of 
three replicates. 
 
5.3.5 Application for AuNR-Based Colorimetric Detection of E. coli 
We tested whether our present enzyme-induced metallization colorimetric assay 
could be used to detect E. coli cells. β-gal was an essential enzyme in the inducible 
lactose transport and metabolism system of E. coli, and was used as indicator for their 
presence.81-83, 125, 199 Because phages can distinguish between live and inactive bacteria, 
their use as detection probes avoids false-positive results.69 As shown in Figure 5.8a, the 
detection process can be divided into two steps: (i) phage infects the target bacterial cells, 
resulting in the release of β-gal into the sample solution, and (ii) determination of the 
released β-gal concentration from bacterial cells was determined using our present 
colorimetric assays. As a result, the bacterial concentration can be determined using UV-
vis absorbance spectra, or conveniently by the naked eyes.  
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Figure 5.8 (a) Schematic illustration of the enzyme-induced metallization colorimetric 
assay for the detection of E. coli cells: (i) phage infection of E. coli cells to release β-gal, 
and (ii) the signal generation based on enzyme-induced silver metallization on the surface 
of AuNRs. (b) UV-vis absorption spectra of the colorimetric assay toward various E. coli 
BL21 concentrations. (c) The blue shift in the longitudinal LSPR peak towards various E. 
coli BL21 concentrations (insert: the corresponding photographs). Error bars represent 
the standard deviation of three replicates. Significant values (t-test) were marked by an 
asterisk (*, 0.01 < p < 0.05) and two asterisks (**, p < 0.01), respectively. 
 
E. coli BL21 was chosen as model analyte and bacteriophage T7 as the infecting 
phage as published previously.200 This AuNR-based colorimetric assay combined the 
advantage of phage-based detection can specifically detection viable E. coli cells. As 
shown in Figure 5.8b, the different blue shifts of the longitudinal LSPR peak were 
observed. The Δλmax of different bacterial concentrations were also plotted in Figure 5.8c, 
revealing that we could reproducibly detect 1 × 104 colony forming units (CFU) mL-1 (p 
< 0.05). The photography showed that the color of the detection solution turned from 
light red to green to pale (Figure 5.8c, insert). In our previous study, the specificity to 
detect E. coli using T7 phage-based method had been reported.200 Thus, These results 
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demonstrated that our present colorimetric assay could successfully detect bacterial 
concentrations.  
5.4 Conclusions 
In summary, a simple and rapid enzyme-induced metallization colorimetric assay 
has been successfully employed to monitor and measure β-gal activity. Compared with 
conventional ONPG-based colorimetric assay, our proposed method had lower detection 
limit (0.128 nM) and board dynamic range (0.1-10 nM) for the detection of β-gal 
concentration. This system also provided a rapid and distinctive colorimetric readout to 
detect the β-gal concentration using bare-eyes. Furthermore, we combined this assay with 
phage lysis to improve the detection of E. coli cells. The proposed technology has the 
ability to be fabricated into inexpensive, portable, friendly-to-user, and disposable 
devices, providing a tremendous benefit to their respective industries, especially if used 
in resource-limited settings.  
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CHAPTER 6 
 
T7LACZ ENGINEERED BACTERIOPHAGE FOR SIMPLE COLORIMETRIC 
DETECTION OF VIABLE ESCHERICHIA COLI  
 
6.1 Introduction 
Bacterial infections remain a critical burden on human health in both developing 
and developed countries, and are globally responsible for the tens of 10 million deaths201, 
202. With the increasing prevalence of antibiotic resistance bacteria, these infections 
further exacerbate the economic and public health costs of treatment203, 204. Traditional 
bacterial detection methods, such as plate counting, can take at least 18 hours after the 
samples are received to provide results. To ascertain whether an isolate is resistant to a 
given antibiotic, can take even longer. To meet the growing demand for sensitive and 
rapid bacteria detection, numerous advanced technologies have been developed to detect 
bacteria, including polymerase chain reaction (PCR), surface-enhanced Raman scattering 
(SERS), and surface plasmon resonance (SPR)16, 205-207. Although sensitive and accurate, 
the above-mentioned methods are expensive, require skilled operators, and are unsuitable 
for use in low-resource settings. Thus, there remains an urgent need to develop 
innovative, inexpensive, sensitive, and rapid methods for in-situ detection of bacteria. 
Bacteriophage (phage) is a virus, which can infect specific host bacterial cells. 
Phage-based amplification assays for bacteria detection have been widely used for food 
safety, environmental monitor, and clinical diagnosis70, 71. Unfortunately, these traditional 
assays are complicated and the long detection time makes their utilization problematic for 
rapid detection of pathogenic bacteria. Advances in molecular genetic technologies have 
provided researchers with new tools to improve upon current phage-based schemes, 
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allowing for sensitive and rapid bacteria detection using engineered phage. A number of 
reporter genes, such as green fluorescent protein, tobacco etch virus protease, alkaline 
phosphatase, and firefly luciferase, have been inserted into phage genomes and 
subsequently used as reporters to improve bacteria detection72, 93, 208.  
Beta-galactosidase (β-gal), encoded by lacZ operon, is commonly used as an 
indicator for the detection of E. coli cells in drinking water81, 83, 115. Phages have been 
incorporated into some of these schemes as lytic agents to break the host cell's membrane 
and release β-gal for colorimetric, electrochemical, and bioluminescent detection of E. 
coli cells81, 83, 125. The sensitivity of these schemes leaves room for improvement. In our 
study, in order to improve detection limit of E. coli cells via β-gal activity, we have 
engineered T7 phage to carry lacZ gene linked to the T7 promoter to induce β-gal 
overexpression during the phage infection cycle. Our strategy for E. coli detection is 
shown in Figure 6.1. After our engineered T7lacZ phages attach to host E. coli cell and 
inject its genome containing our T7 promoter-linked lacZ gene into host E. coli cell, then 
lacZ transcription will be driven by T7 polymerase and translated into β-gal by the 
bacterial ribosome. At the time of phage-induced lysis, both native and overexpressed β-
gal will be released into environmental media. Now free from the cell, the released 
enzyme can catalyze a colorimetric substrate, like chlorophenol red-β-D-
galactopyranoside (CPRG), to provide a visual signal from yellow to red. 
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Figure 6.1 1Schematic illustration of E. coli detection using enzymatically active β-
galactosidase-overexpressed via engineered bacteriophage. Initial infection of E. coli 
cells results in rapid propagation of phages and overexpression of β-gal. Upon phage-
induced cell lysis, both phages and β-gal are released, leading to subsequent infections 
and catalysis of chlorophenol red-β-D-galactopyranoside to produce a colorimetric signal. 
 
6.2 Experimental Section  
6.2.1 Bacterial strains, bacteriophage, and chemicals  
E. coli BL21, E. coli BLT5403, and bacteriophage T7Select415-1 were purchased 
from EMD Millipore (Billerica, MA). The pUC57 plasmid containing lacZ operon was 
synthesized by GenScript (Piscataway, NJ). Phusion PCR kit and restriction enzyme 
(EcoRI and HindIII) were purchased from New England Biolabs (Ipswich, MA). T4 
DNA ligase was purchased from Promega (Madison, WI). The kits for purification of 
PCR product and restriction digests were purchased from Qiagen (Valencia, CA).  
Chlorophenol red-β-D-galactopyranoside (CPRG) was purchased from Roche 
Diagnostics (Indianapolis, IN). All other chemicals were purchased from Fisher Scientific 
(Fair Lawn, NJ). 
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6.2.2 Construction and purification of engineered bacteriophage 
Phage T7Select415-1 kit was used to create T7lacZ phage carrying lacZ gene with 
standard molecular techniques. During phage infection, the engineered T7lacZ phage can 
overexpress intracellular β-gal. The lacZ gene, 3075 base pairs in size, was synthesized 
within pUC57 plasmid. Phusion PCR kit was used to amplify our designed construct. The 
PCR product was then purified and digested by EcoRI and HindIII. T4 ligase was used to 
insert our digested construct to T7Select 415 genome vector arms. T7lacZ phage was 
obtained by packing of the modified lacZ-carrying T7lacZ genome using T7Select packing 
kit. In order to confirm β-gal overexpression by T7lacZ phage performance, the S·Tag was 
used to replace our lacZ inserted construct to create a control phage (T7control), which 
could not express intracellular β-gal during phage infection. The resulting engineered 
T7lacZ and T7control phages were propagated on E. coli BL21 and plated. The isolated 
plaques were checked for the appropriate size insert using Phusion PCR kit with T7Select 
Up and Down primers.  
Prior to be used for phage-based bacterial detection, T7lacZ and T7control phages 
were amplified within E. coli BL21 and purified. Overnight cultures of E. coli BL21 (150 
µL) were added into sterile flasks containing LB broth (35 mL) and incubated at 37 C 
until an OD600 of 0.6 was reached. Then a plug of T7lacZ and T7control phage from the 
confirmed plaques were used to inoculate these cultures, respectively. The flasks were 
incubated with shaking at 37 °C until lysis (the cultures became clear). Lysed cultures 
were centrifuged at 7000x g for 10 minutes, and the supernatants were then filtered using 
0.2 µm filters. The purified solutions were centrifuged at 35,000x g for 2 hours.  Finally, 
the pellets were resuspended into PBS buffer (4 mL) and stored at 4 °C for subsequent 
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experiments. The phage titer (PFU mL-1) was enumerated following standard plaque 
assays. 
6.2.3 Bacteria culture 
The E. coli BL21 was streaked on a LB agar plate. After overnight growth at 37 
°C, a single colony was used to inoculate a sterile flask containing 35 mL LB broth, 
which was then incubated overnight at 37 °C with 200 rpm agitation. The bacteria cells 
were then centrifuged at 6000x g for 2 minutes and resuspended in PBS buffer. The 
washing steps were repeated three times. Finally, the optical intensity of cell pellet in 
PBS buffer was measured and adjusted to 1.0 (~108 CFU mL-1) to create a stock solution. 
Desired bacterial concentrations were obtained by serially dilution of this bacterial stock 
solution and stored for further use at 4 °C.  Bacteria concentration were also confirmed 
by plating on LB agar plates at time of use. 
6.2.4 Comparison of one-step E. coli detection using T7lacZ and T7control phage 
The activity of β-gal expressed by T7lacZ and T7control phage was investigated 
using CPRG as colorimetric substrate. The serial dilutions of bacterial stock (25 µL) were 
added into a sterile centrifuge tubes containing LB broth (190 µL), CPRG solution (10 
µL, 24 mM), and engineered phage solution (25 µL, appropriately 105 PFU·mL-1). These 
mixture solutions were incubated for 7 hours at 37 °C with 200 rpm agitation. The 
absorbance intensity of each solution (200 µL) was measured every one hour using UV-
vis spectrophotometer at the wavelength range of 500-650 nm.  
6.2.5 Two-step detection of E. coli cells using T7lacZ phage 
The impact of a preenrichment step on assay sensitivity and detection time was 
investigated. Bacterial solutions (100 µL) at the concentration of 104, 103, and 102 
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CFU·mL-1 were added to LB broth (760 µL) at 37 °C with 200 rpm agitation. PBS buffer 
without bacteria cells was used as control. After various hours (1-6 hours) of 
preenrichment, CPRG solution (40 µL, 24 mM) and engineered phage solution (100 µL, 
appropriately 105 PFU·mL-1) were added into these solutions. The absorbance intensity of 
each solution (200 µL) was recorded every one hour using UV-vis spectrophotometer at 
the wavelength range of 500-650 nm for a max total assay time of 7 hours. 
6.2.6 Sensing of antibiotic drugs  
For high-throughput drug sensing, E. coli BLT5403 solutions (25 µL, 104 
CFU·mL-1) were incubated in LB broth (190 µL) containing different antibiotic drugs 
with varying concentrations (0, 2, 5, 10, 20, 40, 60, and 100 µg·mL-1) for 3 hours at 37 
°C with 200 rpm agitation. CPRG solution (10 µL, 24 mM) and T7lacZ phage solution (25 
µL, appropriately 105 PFU·mL-1) were then added and incubated for another 2 hours. The 
solutions were analyzed as above mentioned. The E. coli BL21 was used as a control. 
6.2.7 Statistical analysis 
All data were evaluated for statistically significance using t-test and presented as 
mean ± standard deviation. A star (*) and two (**) indicated that tested set of data had a 
difference (0.01 < p < 0.05) and significant difference (p < 0.01) with control set, 
respectively. 
6.3 Results 
6.3.1 Construction of enzymatic reporter-produced bacteriophage 
We modified T7 bacteriophage, which is an E. coli-specific phage and broadly 
infects E. coli strains, to overexpress intracellular β-gal during phage infection209. This 
work was achieved by inserting our lacZ inserted construct into the T7Select415-1 
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genome using EcoRI and HindIII restriction enzyme sites (Figure 6.2a-b). In our 
construction, our lacZ gene was preceded by regulator sequences to enable T7 
polymerase mediated overexpression, and a ribosome binding site for translation by the 
bacterial cell (Figure 6.2c). The T7 promoter is a very strong promoter, and is utilized in 
many gene overexpression schemes. And, a similar overexpression scheme has 
successfully demonstrated the production of over 200,000 copies of an enzymatic 
reporter per cell, enabling bacterial detection93. Furthermore, as previously described, a 
stop codon was incorporated upstream of our β-gal construct to ensure the enzyme was 
not fused to capsid in protein when inserted into the T7Select415-1 genome. As a control, 
T7Select415-1 control DNA, which encodes the S·Tag, was inserted into the T7 genome 
to create T7control phage, which would not express β-gal (Figure 6.2d). After propagating 
our modified phage, lysate were plated and we utilized PCR to select the positive plaques 
that contained our designed lacZ construct and the control DNA. 
 
Figure 6.2 Genomes of engineered bacteriophage used for E. coli detection. (a) Genome 
of lacZ inserted construction. (b) Genome of T7Select415-1 shows 10B capsid protein 
and cloning site. (c) Genome of β-gal-overexpressing T7lacZ phage created by cloning 
lacZ inserted construction into T7Select415-1 genome. (d) Genome of non-β-gal-
overexpressing T7control phage created by cloning S·Tag into T7Select415-1 genome. 
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6.3.2 Characterization of enzymatically active engineered bacteriophage 
After PCR screening, positive T7lacZ and T7control plaques were re-propagated to 
investigate the expression of β-gal during infection. The enzymatic activity of β-gal was 
monitored using CPRG as colorimetric substrate. We measured the UV-vis absorption 
spectra of solutions containing E. coli BL21, CPRG, and our engineered phage (T7lacZ 
and T7control phage, respectively) after the incubation of 3 hour (Figure 6.3a). The 
absorbance intensities at the peak wavelength of 574 nm were plotted towards treatment 
type (Figure 6.3b). The absorbance intensity of solutions contain cells lysed by our T7lacZ 
phage was much greater than that of solutions containing cells lysed by our T7control 
phage, indicating that β-gal was overexpressed during T7lacZ phage infection. In order to 
further confirm that increased absorbance intensity was due to our T7lacZ phage infection, 
more control tests were studied, including E. coli BL21 + T7lacZ, CPRG + T7lacZ, E. coli 
BL21 + CPRG, T7lacZ, CPRG, and E. coli BL21. None of these controls results in 
absorbance intensity equivalent to our E. coli BL21 + CPRG + T7lacZ, further supporting 
that the observed increase in absorbance intensity was due to our T7lacZ phage infection. 
Photographs of detection solution from different treatment types are shown in Figure 6.3b 
and the red color was observed only in the present of E. coli BL21 + CPRG + T7lacZ. 
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Figure 6.3 Comparison of overexpressed β-gal activity with different treatment types. (a) 
UV-vis absorption spectra of different treatment types and (b) plot of absorbance 
intensities (574 nm) towards different treatment types of (i) E. coli BL21 + CPRG + 
T7control, (ii) E. coli BL21 + CPRG + T7lacZ, (iii) E. coli BL21 + T7lacZ, (iv) CPRG + 
T7lacZ, (v) E. coli BL21 + CPRG, (vi) T7lacZ, (vii) CPRG, and (viii) E. coli BL21. (Error 
bars represent one standard deviation of three independent experiments) 
 
6.3.3 One-step detection of E. coli cells using engineered T7lacZ and T7control 
bacteriophage 
We next sought to investigate the ability of our colorimetric scheme to detect E. 
coli cells using T7lacZ and T7control phage. Varying concentrations (101 to 107 CFU·mL-1) 
of E. coli BL21 in LB broth were incubated with either T7lacZ or T7control phage (105 
PFU·mL-1) in the presence of CPRG. LB broth without E. coli cells was used as a 
control. Contour plots of absorbance intensities (574 nm) of the colorimetric response as 
2D function of E. coli BL21 concentration and total detection time using T7lacZ phage and 
T7control phage are shown in Figure 6.4a-b. The color transition from yellow to red was 
scaled using absorbance intensity from 0.0 to 4.0 with an interval of 0.5. As shown, the 
red color indicates the E. coli detectable area incorporating both factors (E. coli cell 
concentration and total detection time). With the increasing of detection time, the 
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detection limit decreased, reaching a limit of 102 CFU·mL-1 after 7 hours using T7lacZ 
phage. In contrast, the E. coli detection limit using T7control phage never went below 105 
CFU·mL-1 even after incubation of 4 hours. As shown in Figure 6.4a-b, the large 
difference in the red area clearly demonstrated the improvement in E. coli detection by 
using T7lacZ phage which induced β-gal overexpression and cell lysis against the T7control 
phage which only resulted in release of endemic β-gal. The corresponding photographs of 
the colorimetric response are shown in Figure 6.4c-d, which are consistent with 
absorbance intensity data. 
 
Figure 6.4 Comparison of one-step E. coli detection using T7lacZ and T7control engineered 
bacteriophage. Contour plots of absorbance intensities (574 nm) of colorimetric response 
as 2D function of E. coli BL21 concentration and total detection time using (a) T7lacZ 
phage and (b) T7control phage. Contour plots of photograph of colorimetric response as 2D 
function of E. coli BL21 concentration and total detection time using (c) T7lacZ phage and 
(d) T7control phage. (The absorbance intensity data shown here represents the average of 
three independent experiments) 
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To further compare the differences in E. coli cell detection using T7lacZ and 
T7control phage, a time course study of bacteria detection can be found in Figure 6.5. 
Although equivalent E. coli cell detection limits were reached using both phages within 3 
hours, T7lacZ phage showed a stronger colorimetric response than T7control phage at the 
same time. After 4 hours, differences became clearer, and a lower limit of detection was 
obtained using T7lacZ phage. As noted, we were able to detect 102 CFU·mL-1 after 7 hours 
using T7lacZ phage, which was driven by phage-overexpressed β-gal. Without 
overexpression of β-gal, the endemic enzyme released from E. coli cells using T7control 
phage resulted in a weaker colorimetric response and 100-fold poorer detection limit of 
104 CFU·mL-1 after 7 hours. These results indicated T7lacZ phage, which induces β-gal 
overexpression upon infection, has the potential to improve the sensitivity of β-gal-based 
detection of E. coli cells. 
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Figure 6.5 Comparison of one-step E. coli detection using engineered T7control and T7lacZ 
bacteriophage. Plots of absorbance intensities (574 nm) towards various E. coli 
concentrations after detection time of (a) 2, (b) 3, (c) 4, (d) 5, (e) 6, and (f) 7 hour. (Error 
bars represent the standard deviation of three independent experiments) 
 
6.3.5 Two-step detection of E. coli cells using T7lacZ engineered bacteriophage 
 Preenrichments steps are commonly used in bacterial detection methodologies and we 
were curious as to the extent such a step could improve our detection time or limit. We 
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diluted an E. coli culture to the following concentrations (103, 102, and 101 CFU·mL-1, 
LB broth was used as control experiment) and allowed them to grow in LB broth for 
various hours at 37 C°. After a set preenrichment time, T7lacZ phage and CPRG were then 
added to start the phage infection and reporter enzyme production. The absorbance 
intensity was measured every hour until a total of 7 hours. Contour plots of absorbance 
intensities at 574 nm as 2D function of detection time and preenrichment time for each 
starting E. coli concentrations can be found in Figure 6.6. It should be noted that 
detectable area (red color) decreased with the decreasing of E. coli concentration. As 
expected, no red color was observed in the control experiment.   
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Figure 6.6 Two-step detection of E. coli cells at low concentrations using T7lacZ 
engineered bacteriophage. Contour plots of absorbance intensities (574 nm) as 2D 
function of detection time and preenrichment time towards E. coli cells at the 
concentration of (a) 103, (b) 102, (c) 101, and (d) 0 CFU·mL-1. (The absorbance intensity 
data shown here represents the average of three independent experiments) 
 
The number of E. coli cells played an extremely important role on colorimetric 
response. In our study, two-step detection (preenrichment step and detection step) was 
incorporated to detect E. coli cells at low concentrations. Preenrichment allowed E. coli 
to grow to increase E. coli cell number, and the detection step was used for phage 
infection and enzymatic reaction. The absorbance intensity at 574 nm was plotted 
towards total detection time (less than 7 hours) at different E. coli concentrations. As 
shown in Figure 6.7, we were able to detect E. coli cells at the concentration of 103, 102, 
and 101 CFU·mL-1 after total detection time of 5, 6, and 7 hours, respectively. Different 
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preenrichment times resulted in slightly differences of colorimetric response, indicting 
that whole detection was mostly contributed by phage infection and enzymatic reaction. 
This phenomenon can be explained that E. coli cells at low concentrations can grow as 
normal because spare cells in the detection solution decreased the opportunity to be 
infected by T7lacZ phage. 
 
Figure 6.7 Two-step detection of E. coli cells at low concentrations using T7lacZ 
engineered bacteriophage. Plots of absorbance intensities (574 nm) towards total 
detection time at the E. coli BL21 concentrations of (a) 103, (b) 102, (c) 101, and (d) 0 
CFU·mL-1. Solid lines indicate the average and ± 3 standard deviation of absorbance 
intensity of control experiments. (Error bars represent the standard deviation of three 
independent experiments) 
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6.3.6 High-throughput sensing of antibiotics 
As a proof-of-principle application for phage-based detection, we explored the 
ability of our modified phage to improve time to result of antibiotic drugs sensing in a 
high throughput, i.e. 96-well plate, format. The E. coli BLT5403, an ampicillin resistant 
E. coli stain, was used as our bacterial model, and we examined phage mediated β-gal 
overexpression in the presence of ampicillin, kanamycin, and ciprofloxacin. The steps of 
our proposed simple, high-throughput, and phage-based antibiotic drugs sensing scheme 
are illustrated in Figure 8a. We inoculated E. coli BLT5403 cells into LB broth 
containing different antibiotics at varying concentrations at 37 °C for 3 hours. T7lacZ 
phage and CPRG were then added to prompt colorimetric response. In the present of 
effective antibiotic drugs, the proliferation of E. coli cells was inhibited, which decreased 
the expression of β-gal after adding T7lacZ phage. Therefore, the detection solution kept 
yellow. In the present of ineffective antibiotic drugs (ampicillin), the E. coli cells 
exhibited exponential growth. The degree of growth inhibition by antibiotic drugs caused 
different amounts of β-gal expressed by T7lacZ phage, resulting in different levels of red 
intensities. 
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Figure 6.8 High-throughput determination of antibiotic drugs using T7lacZ engineered 
bacteriophage. (a) Schematic illustration of high-throughputs antibiotic screening by 
T7lacZ engineered phage infection of E. coli BLT5403. Plot of absorbance intensities (574 
nm) towards various antibiotics concentrations by T7lacZ engineered phage infection of 
(b) E. coli BLT5403 and E. coli BL21. (Error bars represent one standard deviation of 
three independent experiments) 
 
By analyzing the colorimetric response of the sensing system, we were able to 
determine the antibiotic drugs. As shown in Figure 6.8b, T7lacZ phage incorporating with 
E. coli BLT5403 was able to sense ampicillin. In the present of kanamycin and 
ciprofloxacin, absorbance intensity at 574 nm dramatically decreased with the increasing 
of antibiotics concentration. However, we didn’t observe the decrease trend for 
absorbance intensity at 574 nm in the present of ampicillin at varying concentrations. As 
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control, T7lacZ phage incorporating with E. coli BL21 was used to determinate antibiotic 
drugs. All the three antibiotic drugs completely inhibited the cell growth, resulting in that 
all the detection solutions kept yellow (Figure 6.8c). Thus, these results indicated that 
T7lacZ phage had the potential to determine antibiotic drugs, and even screen new 
antibiotic drugs. 
6.4 Discussion 
In this study, we demonstrated that a scheme utilizing engineered T7lacZ phage, 
that induces   β-gal overexpression during infection, resulted in an improved time to and 
limit of E. coli detection in comparison to a scheme utilizing non-reporter enzyme-
produced phage. The colorimetric response from phage-mediated β-gal enzymatic 
activity was driven by two factors.  The first factor is the number of E. coli cells infected 
by our phage, which was impacted by initial cell concentration, preenrichment time, and 
phage concentration. After low concentration of E. coli cells was inoculated into fresh LB 
broth, the cell proliferation started. It is no doubt that higher initial cell concentration and 
longer preenrichment time could quickly increase the number of E. coli. In addition, 
phage concentration played an important role for the cell number. The E. coli cells at low 
concentrations decreased the probability to be infected by phage, resulting in more time 
for cell proliferation. The second factor was enzymatic reaction, which triggered the 
readable signal. Reaction time as well as pH and temperature had a significant effect on 
the enzymatic product. Like the number of E. coli cells affected by phage concentration, 
phage concentration could determine enzymatic reaction time. In conclusion, phage 
concentration was a key parameter to balance cell growth time and enzymatic time to 
reach best detection efficiency. 
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The efficiency of detection was judged by their specificity, sensitivity, and speed. 
In previously reported publication, the specificity of T7 phage for E. coli detection has 
been demonstrated in the presence of competitive bacterial species, including Salmonella 
enterica, Staphylococcus aureus, and Pseudomonas aeruginosa96. In this study, we 
demonstrate the sensitivity of our scheme, though there is trade off between sensitivity 
and time to result. Several methods could be used to further improve the detection limit 
or shorten the detection time using engineered T7lacZ phage. For example, promoter 
optimization could allow for increased β-gal product176. A more sensitive transduction 
method could be used to monitor the activity of β-gal, like an ultrasensitive enzymatic 
reaction incorporating redox cycling or multi-enzyme labels210. There is also the potential 
to use a concentration step, like membrane filtration, to increase E. coli concentrations 
prior to the addition of T7lacZ phage81, 83, 97. In our DNA construct, a biotin tag was fused 
to the phage capsid protein, which in the future may enable us to bind our engineered 
phages to streptavidin-conjugated magnetic beads allowing further schemes that combine 
sample purification, concentration, and detection40. 
While our proof-of-principle is limited to detection of E. coli cells, there is clear 
potential to adapt our phage-mediated reporter design to other phage that target other 
bacterial pathogens with public health relevance, such as Salmonella and Listeria 
monocytogenes. There is also the potential, as we grow our understanding of phage 
infections, that genetic technologies will allow us to modify phage proteins responsible 
for cell attachment, and thus allowing us to redefine the host range of our T7lacZ phage211. 
Phage cocktails have also gained a wide interest in the areas of phage therapy, reduction 
of biofilm, and prevention of pathogenic disease212-215. A cocktail of β-gal active 
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engineered phage may also be a potential route to broaden our range of detectable 
bacterial strains.  
As a proof-of-principle application, T7lacZ phage incorporating with ampicillin 
resistance E. coli had been demonstrated to sense ampicillin against kanamycin and 
ciprofloxacin. This design could be used to sense other antibiotic drugs using T7lacZ 
phage combining with other antibiotic resistance E. coli strains. In addition, our T7lacZ 
phage may be used to determine antibiotic susceptibility of E. coli strains by monitoring 
bacteria growth in antibiotic LB broth. As shown in Figure 6.8b and Supplementary 
Figure 6.8c, both E. coli BL21 and BLT5403 showed a higher minimal inhibitory 
concentration (MIC) for kanamycin than ciprofloxacin. Our proposed methods to sense 
antibiotic drugs or determine antibiotic susceptibility of E. coli at a high throughput 
format could improve time compared with traditional tests203, 216. 
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CHAPTER 7 
 
CONCLUSIONS 
 
We demonstrate a bacteriophage (phage)-based magnetic separation scheme for the rapid 
detection of Escherichia coli (E. coli ) in drinking water.T7 phage covalently conjugated 
to carboxylic acid-modified magnetic beads were used to capture, separate, and purity E. 
coli cells in drinking water. Our scheme was as follows: (1) T7 phage conjugated 
magnetic beads were used to capture and separate E. coli BL21 from drinking water; (2) 
subsequent phage mediated lysis was used to release endemic β-gal from the bound 
bacterial cells; (3) the release of β-gal was detected using chlorophenol red-β-D-
galactopyranoside (CRPG), a colorimetric substrate which changes from yellow to red in 
the presence of β-gal. Using this strategy, we were able to detect E. coli at a 
concentration of 1 × 104 CFU·mL-1 within 2.5 h. The specificity of the proposed 
magnetic probes toward E. coli was demonstrated against a background of competing 
bacteria. By incorporating a pre-enrichment step in Luria-Bertani (LB) broth 
supplemented with isopropyl β-D-thiogalactopyranoside (IPTG), we were able to detect 
10 CFU·mL-1 in drinking water after 6 hour of pre-enrichment.  
The lack of practical methods for bacterial separation remains a hindrance for the 
low-cost and successful development of rapid detection methods from complex samples. 
Antibody-tagged magnetic particles are commonly used to pull analytes from a liquid 
sample.   While this method is well-established, improvements in capture efficiencies 
would result in an increase of the overall detection assay performance. Bacteriophages 
represent a low-cost and more consistent biorecognition element as compared to 
antibodies. We have developed nanoscale bacteriophage-tagged magnetic probes, where 
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T7 bacteriophages were bound to magnetic nanoparticles. The nanoprobe allowed the 
specific recognition and attachment to E. coli cells. The phage magnetic nanprobes were 
directly compared to antibody-conjugated magnetic nanoprobes. The capture efficiencies 
of bacteriophages and antibodies on nanoparticles for the separation of E. coli K12 at 
varying concentrations were determined. The results indicated a similar bacteria capture 
efficiency between the two nanoprobes. 
The colorimetric detection of pathogens in a food matrix remains the major 
disadvantage of poor visible color change. Although significant work has been performed 
in the area of colorimetric detection, these methods are often expensive and complicated. 
The field of enzymatic nanostructure-based visual detection of pathogens is still in its 
early stage and therefore molecule-based visual assays are most used. Here, A novel 
enzyme-induced metallization colorimetric assay was developed to monitor and measure 
β-gal activity, and was further employed for colorimetric phage-enabled detection of E. 
coli. This assay relied on enzymatic reaction-induced silver deposition on the surface of 
gold nanorods (AuNRs). In the presence of β-gal, the substrate p-aminophenyl β-D-
galactopyranoside (PAPG) is hydrolyzed to produce p-aminophenol (PAP). Reduction of 
silver ions by PAP generates a silver shell on the surface of AuNRs, resulting in the blue 
shift of the longitudinal localized surface plasmon resonance (LSPR) peak and multicolor 
changes of the detection solution from light green to orange-red. Additionally, this 
technique was successfully applied to E. coli detection in combination with phage 
infection. Due to the simplicity and short incubation time of this enzyme-induced 
metallization colorimetric method, the assay is well suited for the detection of bacteria in 
low-resource settings. 
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A T7 bacteriophage (phage) has been genetically engineered to carry the lacZ 
operon to enable the overexpression of beta-galactosidase (β-gal) during phage infection 
for colorimetric detection of Escherichia coli (E. coli) cells. After phage infection, the 
enzymatic activity of the released β-gal was monitored using a colorimetric substrate. 
Compared with a control T7 phage, our T7lacZ phage resulted in significantly higher 
levels of β-gal expression during phage infection, enabling a lower detection limit of E. 
coli cells. Using this engineered T7lacZ phage, we were able to detect E. coli cells at the 
concentration of 10 CFU·mL-1 within 7 hours. Furthermore, we demonstrated the 
potential for phage-based antibiotic drug sensing by using our T7lacZ phage, and 
subsequent β-gal expression to detect ampicillin resistant E. coli cells.  
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